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Abstract 
Macrophages are master regulators of inflammation, fibrosis and wound-healing throughout the body. 
However, little work to date has examined their role in the inflammatory and fibrotic diseases of the 
eye. Mounting evidence for macrophage participation in the failure of intraocular implants (called 
posterior capsule opacification or PCO), and the well-established role of dysfunctional macrophage 
behaviour during diabetes motivated this investigation.  
A novel in vitro model of macrophages and lens epithelial cells in co-culture was developed 
and first used to investigate the macrophage response to common intraocular lens materials, and the 
possible effect of this response on lens epithelial cells. We observed significant inflammatory 
macrophage activation and reduced macrophage adhesion by hydrophilic implant surfaces compared 
to hydrophobic ones. However, the macrophage response to both materials induced the same degree 
of inflammation in lens epithelial cells. In agreement with previous studies, we conclude that 
macrophage adhesion and activation are inversely related, and that net inflammatory effect is a 
function of the degree of macrophage activation and the number of activated cells. 
The in vitro model was next used to explore the development of diabetic cataract. During 
hyperglycemic conditions a significant disruption of macrophage protein expression and delayed 
macrophage cell-death were observed, which may explain adverse inflammation in diabetes. Lens 
epithelial cell phenotype remained unchanged, though results from our in vitro model also suggest 
that lens epithelial cell death as a result of hyperglycemia occurs through a mechanism other than 
apoptosis, in agreement with the literature. We therefore provide additional evidence to the 
hypothesis that diabetic cataracts are a product of accumulated oxidative stress during hyperglycemia. 
Our findings provide a new method of inquiry into macrophage biocompatibility testing of intraocular 
materials, specifically through quantification of macrophage cell-surface markers and lens epithelial 
cell cytoskeletal elements. 
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Chapter 1 
Introduction 
1.1 Motivation 
Of all human senses, vision is perhaps most crucial to the maintenance of a high quality of life. The 
loss of vision, called blindness, is life-altering and world-wide is most often caused by the 
development of cataract,1 or a clouding of the crystalline lens in the eye. The lens is the naturally 
clear structure of the eye responsible for accommodation, the ability of the eye to focus on objects at 
varying distances. An atypically visible cataract is shown below in Figure 1.1. Although our 
understanding of the etiology of cataract is incomplete, we now know that there is a strong genetic 
component to the disease.2 As well, the onset of cataract is associated with the accumulation of 
damage to the lens over time from exposure to ultraviolent B (UVB) radiation, and oxidants from 
poor dietary and lifestyle choices or diabetes.2 Globally, more than 20 million people are blind as a 
result of untreated cataract.3 As global health care improves and life expectancy increases, so too will 
the number of people rendered blind by age-related cataract. 
 
Figure 1.1: Photograph of female patient with cerulean cataract. Reprinted with permission 
from Dr. Arif O. Khan. Copyright Molecular Vision, 2009.4 
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At present, the only treatment for cataract is the surgical removal of the lens and its 
substitution with an artificial implant known as an intraocular lens (IOL), commonly made from 
foldable acrylic and silicone materials but originally made from rigid polymethylmethacrylate 
(PMMA). Modern cataract surgery, called phacoemulsification, involves perforation of the outer 
layers of the eye through a small incision and the emulsification and aspiration of the lens using an 
ultrasound device.5 Patients recovering from cataract surgery generally enjoy much-improved visual 
acuity and a return to normalcy. However, in some cases, the trauma of surgery and subsequent 
implantation of an IOL induce the formation of a secondary cataract.6 Posterior capsular opacification 
(PCO) is one form of secondary cataract and the most frequent complication of cataract surgery, 
occurring in 38.5% of patients after 3 years.7 Despite decades of effort to improve surgical techniques 
and IOL design, PCO remains an important issue in ophthalmology.1 
1.2 Anatomy of the Eye 
The eye is a major sensory organ of the human body that enables vision. The eyeball, formally called 
the globe, is housed within the eye socket, a bony invagination of the skull known formally as the 
orbit. The gross anatomical structures of the globe are shown below in Figure 1.2. The walls of the 
globe comprise three layers of tissue with specific functions. The sclera is the protective, collagenous 
outermost layer of the globe. Although opaque and white, the anterior portion of the sclera – called 
the cornea – is transparent and enables passage of light to the interior of the globe. The uvea is the 
vascularized middle layer of the globe, and provides nutrients and gas exchange to the avascular 
tissues of the globe. The uvea also acts as a selective barrier between the blood and fluids of the eye 
called the aqueous humor. The anterior portion of the uvea – called the iris – is located behind the 
cornea and is responsible for dilating or constricting the aperture, or pupil, of the eye. The medial 
portion of the uvea – called the ciliary body – is a complex muscular structure responsible for 
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changing the shape of the lens (as part of the process of accommodation), as well as producing the 
aqueous humor. The lens, located behind the iris and surrounded by the ciliary body, focuses light 
onto the innermost layer of the globe, the retina. The retina is an epithelial layer of the globe that 
converts stimulation by photons into nerve impulses that are transmitted along the optic nerve into the 
visual centers of the brain. Typically, the anterior structures of the eye up to and including the lens are 
referred to as the anterior segment of the eye. 
 
Figure 1.2: Gross anatomy of the human eye. Reprinted with permission from Elsevier. Source: 
A. W. Lloyd et. al, Biomaterials, 22, 2001.8 
1.2.1 The Anterior Chamber 
Within the anterior segment of the eye are two fluid-filled compartments: the Anterior Chamber, 
located between the corneal endothelium and the iris, and the comparatively smaller Posterior 
Chamber, located between the iris and the lens, and bounded along its equator by the ciliary body. 
Both compartments are filled with a clear fluid called the aqueous humor, which provides nutrients 
and removes metabolic by-products from the avascularised tissues of the cornea and lens. Aqueous 
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humor is produced primarily by active transport, diffusion and ultrafiltration of plasma proteins and 
nutrients across the ciliary epithelium into the posterior chamber.9 
Although often compared to a blood plasma dilution, the aqueous humor has a unique 
chemical composition, as shown below in Table 1.1. By concentration, the aqueous humor is almost 
entirely water, with five-hundred times less protein than plasma (11 mg per 100 mL compared to 6 g 
per 100 mL in plasma).10 The aqueous contains an elevated level of the antioxidant ascorbic acid,11 
but lower glutathione.12,13 Although glucose and urea are roughly 80% of their plasma 
concentrations,14 higher concentrations of pyruvate,15 lactate and bicarbonate are found in the aqueous 
humor.16 Amino acids appear in various concentrations relative to plasma due to active transport 
processes across the ciliary epithelium.17 Immunoglobulins, or antibodies, are the attack and labeling 
proteins of the immune system, and are found at less than 1% of their serum concentration,18 
suggesting that other mediators may be responsible for the intraocular immunological response. 
Table 1.1: Comparison of the mass compositions of blood plasma and aqueous humor 
Component Plasma Concentration  
(per 100 mL) 
Aqueous Concentration  
(per 100 mL) 
Protein 6 g 11 mg 
Ascorbic Acid 0.35 mg 14.9 mg 
Glutathione 0.11 mg 0.059 mg 
Glucose 104 mg 58 mg 
Urea 43.8 mg 37.8 mg 
Pyruvate 1.94 mg 5.81 mg 
Lactate 38.3 mg  65.9 mg 
Bicarbonate 134.2 mg 155.6 mg 
Amino Acids Varies Various Ratios to Plasma, 0.08 to 3.14  
Immunoglobulins 1.3 g 7 mg 
Information gathered on: protein,10 ascorbic acid,11 glutathione,12,13 glucose and urea,14 
pyruvate,15 lactate and bicarbonate,16 amino acids,17 immunoglobulins.18 
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The ciliary epithelium and the endothelium of capillaries within the ciliary body form a 
physical and immunological barrier called the blood-aqueous barrier (BAB). The BAB, along with 
other similar barriers throughout the eye, confer the properties of immune privilege to the intraocular 
environment.19 Immune privilege is believed to be an evolutionarily conserved trait that protects 
critical tissues from inflammation due to injury or infection.20 Immune privilege in the intraocular 
environment is discussed in Chapter 1.3.3.  
1.2.2 The Lens 
Located behind the iris, the lens is bathed in aqueous humor and connected along its equator to the 
ciliary body by suspensory ligaments known as the Zonule of Zinn. Physiologically, the lens is 
comprised of three parts: (1) the lens capsule, a type-IV collagen-rich basement membrane 
surrounding the lens, (2) the lens epithelium, a monolayer of lens epithelial cells on the inner surface 
of the anterior lens capsule, and (3) the lens fibres, transparent, enucleated cells filling the volume of 
the lens.9 During cataract extraction, the surgeon pierces the lens capsule and attempts to remove the 
epithelium in its entirety. Oftentimes, however, islets of lens epithelial cells survive and experience 
rapid regrowth and migration on the anterior surface that may continue onto the previously cell-free 
posterior capsular surface, causing the scattering of light.6,21.Some surviving lens epithelial cells 
undergo transdifferentiation into myofibroblast cells via a process called the epithelial-mesenchymal 
transition (EMT), leading to the pathological expression of the contractile protein α-smooth muscle 
actin (α-SMA), increased expression of the mobility protein vimentin, and a loss of expression of 
type-IV collagen and the intercellular cadherin E-cadherin.22 These myofibroblasts induce fibrosis by 
overproducing proteins of the extracellular matrix (ECM) such as fibronectin, type-I and type-II 
collagen, and tenascin.22 As a result, the lens capsule wrinkles, causing the substantial loss of vision 
experienced during PCO.21 Proteins differentially regulated during PCO are listed below in Table 1.2. 
  6 
Table 1.2: Changes in expression of lens epithelial cell proteins during PCO. 
Protein Nominally Expressed Pathologically Expressed 
α-SMA No Yes 
Vimentin Yes ↑ 
Fibronectin Yes ↑ 
E-cadherin Yes No 
Tenascin Yes ↑ 
Type-I Collagen Yes ↑ 
Type-III Collagen Yes ↑ 
Type-IV Collagen Yes No 
 
1.3 Cells and Components of the Immune System 
The immune system is the collective defense of the human body to invasion by microorganisms that 
cause disease; called pathogens, these organisms include bacteria, fungi, parasites and viruses.23 
Without a functioning immune system, an infection cannot be halted, and human survival is all but 
impossible. The immune system is also involved in the host reaction to an implanted biomaterial 
called the foreign body response. The immune system begins with physical and chemical barriers to 
pathogens, namely the epithelium of the skin which consists of multiple layers of highly keratinized 
(tough and fibrous) cells.23 Once through the epithelium, pathogens are quickly identified and 
attacked by elements of the innate immune system, the first subsystem of the overall immune system. 
The innate immune system is contrasted in function by the second subsystem, the adaptive immune 
system. All cells of both immune subsystems are called leukocytes (white blood cells) and are derived 
from the same progenitor cells in the bone marrow called hematopoietic stem cells.23 
The innate immune system – so named because it is genetically inherited and does not change 
over the lifespan of an organism – is immediate in its identification of pathogens through one of two 
means: pattern recognition receptors, and complement. Pattern recognition receptors are cell-surface 
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proteins expressed on cells of the innate immune system that recognize pathogen-associated 
molecular patterns.24 Complement is a complex system of proteins in blood that, once activated, bind 
to the surface of a pathogen, both marking the pathogen for attack and providing a means of adhesion, 
a process called opsonization.25 The identifying cells then activate the innate immune response by the 
secretion of soluble proteins called cytokines. Cytokines are low molecular weight proteins (~30 kDa 
or less) produced and secreted by cells of the body to control cell growth and differentiation, remodel 
tissue, and to induce or suppress immunity and inflammation.26 Inflammation is the symptom of an 
ongoing innate immune response and results from the recruitment of innate immune cells out of the 
circulatory system and into the site of infection where they can destroy pathogens and infected cells. 
 The cells of the innate immune system can be broadly separated into one of two categories: 
phagocytic cells that devour and destroy foreign pathogens, and cytotoxic cells that destroy pathogen-
infected host cells.27 All phagocytes are derived from the same myeloid progenitor stem cell in bone 
marrow. Neutrophil granulocytes are the most abundant cell of the innate immune system and are 
heavily involved in the early stages of inflammation,28 often described as the “first responders” of the 
immune system and noted for their ability to rapidly secrete reactive oxygen species in a process 
called oxidative burst.29 Reactive oxygen species (ROS) are highly oxidative molecules produced by 
leukocytes like the neutrophil and monocyte/macrophage to attack and destroy pathogens and foreign 
bodies.30 Monocytes are longer-lived phagocytes of the innate immune system that circulate the body 
in the bloodstream. Once recruited out of the circulatory system by an inflammatory signal, 
monocytes differentiate into either macrophages, the tissue-resident phagocytic cells of the innate 
immune system,31 or dendritic cells. Dendritic cells are responsible for the presentation of pathogenic 
material to cells of the adaptive immune system in a process called antigen presentation.32 Antigens 
are molecules that induce an adaptive immune response. 
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 Instead of targeting pathogenic microorganisms, cytotoxic cells target host cells that are 
infected with pathogenic material like viruses.27 The cytotoxic cells of the innate immune system, 
called Natural Killer (NK) cells, are a class of cytotoxic lymphocytes responsible for the destruction 
of cancerous or infected host cells within the body.33 NK cells induce apoptosis in their targets by 
secreting the membrane pore-forming protein perforin followed by caspase activating enzymes.34 
Caspases are essential enzymatic regulators of apoptosis, the process of programmed cell death.35 The 
function of the NK cell in the innate immune system is mirrored by the cytotoxic T-cell in the 
adaptive immune system. 
 The adaptive immune system, also called the acquired immune system, produces a highly-
specific and highly-severe immune response to a pathogen that can be recalled rapidly during 
subsequent invasions in a process called immunological memory.23 Unlike the innate immune system, 
cells of the adaptive immune system recognize one specific antigen, but are able to mount a more 
substantial immune response.36 Similar to the innate immune system, however, adaptive immunity 
has both a cell-mediated (action by cells) and humoral (action by circulating molecules) response.23 T 
cells are responsible for cell-mediated adaptive immunity and have distinct subsets with distinct 
functions. Cytotoxic T cells detect antigens on infected host cells and, like cytotoxic NK cells, 
destroy them.23 Helper T cells secrete cytokines to recruit and direct the innate and adaptive immune 
responses towards the destruction of their antigen.23 Helper T cells also work to maintain immunity to 
a pathogen by promoting immunological memory of their antigen.23 Regulatory T cells work opposite 
to their peers and suppress the immune response to an antigen instead of promoting it, often through 
the production of anti-inflammatory and immunosuppressive cytokines.23 B cells are responsible for 
humoral adaptive immunity, and also have specific subsets and functions. Plasma B cells produce and 
secrete into the circulation proteins of the immune system called antibodies (or immunoglobulins).23 
Antibodies are highly specific to an antigen and may be used to identify, opsonize, or, neutralize a 
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pathogen by blocking the action of a vital protein on that pathogen’s surface.36 Lastly, memory B 
cells maintain humoral immunity to a pathogen by maintaining immunological memory of their 
antigen.23 A summary of the various cells of the innate and adaptive immune systems are shown 
below in Table 1.3. 
Table 1.3: Cells of the Immune System and their Function 
Subsystem Component Immune Function 
Innate 
Neutrophils Acute inflammation, phagocytosis, ROS production 
Monocytes Replenishment of tissue phagocytes, phagocytosis, ROS 
Macrophages Phagocytosis, sustained inflammation, antigen-presentation, ROS 
Dendritic cells Antigen-presentation, phagocytosis 
NK cells Destruction of infected host cells 
Complement Opsonization, cell lysis 
Adaptive 
Cytotoxic T cell Destroy infected host cells after detecting specific antigen 
Helper T cell Secrete cytokines to direct immune response, maintain memory 
Regulatory T cell Suppress immune response to a specific antigen 
Plasma B cell Produce antibodies for specific antigen 
Memory B cell Maintain immunological memory to specific antigen 
Antibody Identify, opsonize, or, neutralize pathogens via blocking 
Information gathered on the innate immune system,23,27 and the adaptive immune system.23,36 
 
1.3.1 The Macrophage 
Macrophages are the resident phagocytic cells of the innate immune system, derived by the 
differentiation of monocytes in tissue.31 Macrophages are highly responsive to their tissue 
environment and may exhibit a combination of host defence, wound healing and immunoregulatory 
phenotypes.37 The exact nature of macrophage activation can be characterized by examining the 
expression of cell-surface proteins involved in the foreign-body response, like the cluster of 
differentiation (CD) proteins CD14, CD36 and CD54, as well as the production of reactive oxygen 
species (ROS) and reactive nitrogen species (RNS), which are used to chemically degrade targets of 
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macrophage attack.38 Examination of cell-surface proteins associated with macrophage adhesion can 
also be used to characterize activation. The production of membrane-bound particles by activated 
macrophages via blebbing or shedding, called microparticles, provide a means of intercellular 
communication during inflammation and can also be examined. A summary of macrophage cell-
surface markers relevant to macrophage function during inflammation is included below in Table 1.4. 
Table 1.4: Macrophage cell-surface proteins and their function during inflammation 
Protein Receptor Class Inflammatory Function 
CD11b Integrin Adhesion, complement-mediated phagocytosis 
CD11c Integrin Adhesion, complement-mediated phagocytosis 
CD14 Pattern recognition Detection and phagocytosis of bacteria 
CD36 Scavenger Phagocytosis of apoptotic cells 
CD45 Integrin Leukocyte common antigen 
CD54 Integrin Adhesion, complement-mediated phagocytosis 
CD68 Scavenger Phagocytosis of apoptotic cells 
CD163 Scavenger Phagocytosis of apoptotic cells 
Fc Immunoglobulin Antibody-mediated (opsonized) phagocytosis 
MRC1 Pattern recognition Mannose residue recognition, pinocytosis 
TLR2 Pattern recognition Rapid detection and phagocytosis of bacteria 
TLR4 Pattern recognition Rapid detection and phagocytosis of bacteria 
Information gathered on pattern recognition receptors24,39,40integrins,39,41 scavenger 
receptors,41–43 and the immunoglobulin superfamily of receptors (Fc).39 
The cell-surface proteins CD11b, CD11c, CD14, CD36 and CD54 are of particular 
importance to this investigation. CD11b, also known as Integrin Alpha M, enables macrophage 
adhesion and migration and is upregulated on macrophages during systemic inflammatory conditions 
like obesity and diabetes.44–48 CD11c, also known as Integrin Alpha X, is functionally cooperative 
with CD11b and regulated similarly.49,50 Intercellular adhesion molecule-1 (ICAM-1), also known as 
CD54, is upregulated on macrophages in response to foreign-body stimuli in vitro,51–53 and in 
vivo,54,55 as well as during diabetes. CD36, a multi-ligand scavenger receptor, is down-regulated in 
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macrophages by the anti-inflammatory, wound-healing cytokine TGF-β and up-regulated by a select 
number of pro-inflammatory cytokines,56,57 and is therefore useful for examining the wound-healing 
response of macrophages. CD14 is a pattern recognition receptor for bacterial and viral pathogens58 
and can be used to specifically examine the contribution of microbial contamination to the overall 
host-defence response.  
Three secretory products of the macrophage have been identified as crucial chemical 
mediators of PCO. The primary mediator of PCO has been demonstrated both in vitro and in vivo to 
be the cytokine transforming growth factor beta (TGF-β).59–66 Additionally, members of the matrix 
metalloproteinase (MMP) family – specifically MMP-2 and MMP-9 – have been shown to play a 
regulatory role in the formation of PCO.22 Macrophages are well understood to play a crucial role in 
regulating inflammatory processes and the wound-healing response to biomaterials.31,67,68 
Macrophages are also important cellular mediators of fibrotic diseases elsewhere in the body,69,70 
suggesting they may play a role in PCO. 
1.3.1.1 Measuring Macrophage Activation using Flow Cytometry 
Expression of macrophage cell-surface proteins can be directly measured using flow cytometry. A 
flow cytometer is a measurement device that operates by passing cells in front of a laser one-by-one 
to gather information about their size, granularity, and fluorescence. Proteins of interest can be 
labelled on a cell using antibodies that are chemically conjugated with a fluorescent molecule called a 
fluorophore. By choosing fluorophores with different emission spectra, units of fluorescence 
measured from the flow cytometer can be used to determine the relative quantities of multiple 
proteins present on each cell of a culture. This is in contrast to other protein-quantification methods 
like Western Blotting, where a single measurement of expression is given for the entire culture. Flow 
cytometry also enables post-acquisition analysis like gating, which is the separation of flow 
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cytometry data into distinct subsets based on measured properties, like the separation of leukemia 
cells from healthy leukocytes based on fluorescently-labelled CD45.71 
1.3.2 Macrophage Response to Biomaterials 
Macrophages are often studied for their pivotal role in the foreign body reaction to 
biomaterials,31,67,68 which are materials intended to interact with biological systems. Since the 
implantation of a biomaterial necessitates surgery, a central theme in biomaterials research is the 
design of materials and drug-delivery systems that can modulate the wound-healing response for the 
better.72 The wound healing response is best described as four stages with varying degrees of overlap: 
hemostasis, inflammation, proliferation and remodeling.73 Following trauma, blood enters the wound 
site and clots, resulting in hemostasis.74 Inflammation at the wound-site begins as polymorphic 
neutrophils enter and phagocytize bacteria, foreign debris and damaged tissue before undergoing 
apoptosis.73 Macrophages subsequently enter the wound-site and continue the inflammatory reaction, 
while stimulating angiogenesis, the growth of new capillaries and the beginning of the proliferation 
phase, by secreting platelet-derived growth factor (PDGF) and TGF-β.31 The proliferation phase is 
named for the proliferation of fibroblasts and characterized by the rapid deposition of collagenous 
ECM throughout the wound bed, which is eventually reoriented and further modified in the 
remodelling phase.74 Typically, the wound-healing response results in a resolved wound with no 
further activity. However, in the case of an implanted biomaterial, low levels of inflammation persist 
indefinitely in a process known as the foreign body reaction.75 This unique reaction is driven 
primarily by the macrophage and their multi-nucleated successor, the foreign body giant cell (FBGC). 
The key to modulating the foreign body reaction, then, is to modulate the interaction between 
macrophages and material. 
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Upon contact with blood, a biomaterial is rapidly covered with blood plasma (serum) 
proteins, namely albumin, fibrinogen, fibronectin, vitronectin, gamma globulin, complement, and von 
Willebrand factor, in a non-binding and reversible process called adsorption.31,76 Once adsorbed, 
serum proteins interact with the integrins of monocytes and macrophages and direct not only 
macrophage adhesion, but inflammatory activation, apoptosis, and fusion into FBGCs. The order of 
and rate at which these proteins adsorb to a material is largely determined by that material’s surface 
chemistry.77,78 The specific properties of a surface that affect protein adsorption are: (1) interfacial 
free energy, (2) hydrophobic (water repelling) or hydrophilic (water attracting) behaviour, (3) 
functional groups present, (4) type and quantity of ionic charge, and (5) topography and roughness.77 
Extensive work in the literature has determined that of central concern to macrophage-biomaterial 
interaction is the degree of hydrophobicity or hydrophilicity of a surface.79 Hydrophilic surfaces in 
particular have been shown to strongly increase inflammatory activation of macrophages compared to 
hydrophobic surfaces.80 This increase in inflammatory activation is paradoxically accompanied by a 
strong resistance to macrophage adhesion onto hydrophilic surfaces.79 
1.3.2.1 Macrophage Response to IOLs 
Although damage to the BAB during phacoemulsification may permit blood interaction with 
IOLs, blood components entering the anterior and posterior chambers will likely be diluted by 
aqueous humor. Correspondingly, few studies have examined the interaction of IOL materials with 
blood.81,82 Despite mounting evidence of macrophage presence in PCO, the leukocyte 
biocompatibility of IOL materials (often referred to as uveal biocompatibility) and its potential 
contribution to the development of PCO have rarely been investigated. One important finding 
regarding uveal biocompatibility is the effect of implant surface chemistry on the leukocyte response 
to intraocular materials;83–85 an observation reinforced by our current understanding of macrophage 
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biocompatibility elsewhere in the body.80 In the eye, macrophages have been observed on the surface 
of IOLs explanted from human patients.86–89 In an animal model of PCO, depletion of macrophages 
reduced the number of lens epithelial cells in the center of the posterior capsule,90 suggesting that 
macrophages may play a role in lens epithelial cell mobility during PCO. Despite this evidence, few 
studies have investigated the leukocyte biocompatibility of IOL materials (often referred to as uveal 
biocompatibility) and its potential contribution to PCO development. To date, uveal biocompatibility 
has been measured by counting the number of adherent leukocytes on the surface of an IOL,83–85 the 
hypothesis being that a higher number of adherent cells indicates a less biocompatible material. Meta-
studies of IOL biocompatibility in vivo have noted a lower incidence rate of PCO in patients using 
IOLs with hydrophobic surfaces compared to hydrophilic surfaces of the same haptic design.83,91–93 
However, a causative link between leukocyte biocompatibility in the post-operative lens and PCO 
development remains unclear. Additionally, there is limited information on the potential for IOL 
materials to induce an inflammatory response in leukocytes, how this response is related to adhesion, 
and how the release of macrophage inflammatory mediators may affect lens epithelial cells. 
1.3.3 Immune Privilege 
Classically, immune privilege has been thought of as immunological ignorance, where a tissue graft 
could survive in a region of the body without immune rejection.94–96 This definition, however, has 
since been broadened as the cells and molecular environments that facilitate prolonged allograft 
survival have become increasingly well understood. Modern thinking about immune privilege is 
perhaps confounded with the notion that immune privileged sites are able to resolve inflammation 
without provoking typical white blood cell (or leukocyte) mediated immune responses. An 
assumption is often made that immune privileged environments are therefore absent of leukocytes, 
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but in many cases this is incorrect, and certain leukocytes may be present and active in immune 
privileged sites.i 
Several organs in the body are immune privileged, including the brain, the eye, and the 
testes.97 The eye is of particular interest to studies of immune privilege since the ocular surface has to 
contend with pathogens on a daily basis. Additionally, the eye is the target of many biomedical 
devices, including contact lenses, intraocular lenses, and glaucoma drainage devices. Indeed, there are 
many cases where biomaterial interactions may exacerbate inflammation or are implicated in adverse 
events like PCO.98 We now understand that ocular immune privilege is a complex and active system 
of immunosuppressive mediators coupled with the selective recruitment of innate and adaptive 
immune cells across the BAB into the aqueous humor during normal and pathological states.95 It 
follows then that studies of material biocompatibility in the eye should expand to include leukocyte 
biocompatibility.i  
1.3.3.1 The Aqueous Humor and Immune Privilege 
The aqueous humor, under normal circumstances, contains a high concentration of 
immunosuppressive and anti-inflammatory molecules that reinforce the immune privileged tissue 
microenvironments of the inner eye. These molecules fall into the broad categories of signaling 
molecules called cytokines. The aqueous humor appears to contain a careful mixture of cytokines to 
modulate a number of cellular properties. Specifically, extracted aqueous humor has been 
demonstrated to suppress reactive oxygen species generation in macrophages in vitro by calcitonin 
gene-related peptide (CGRP).99 Aqueous humor also inhibits NK cell target lysing via macrophage 
migration inhibitory factor (MIF), and suppresses CD95-induced neutrophil activation via soluble 
                                                     
i These paragraphs were co-authored with Cameron Postnikoff as part of an as-yet unsubmitted review paper on 
immune privilege in the anterior eye and its role in material biocompatibility. 
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CD95 ligand.100 CD95 is also known as Fas ligand or apoptosis antigen-1, and apoptosis is induced by 
CD95 receptor-ligand activity.101  
A large portion of the aqueous humor’s anti-inflammatory properties can be attributed to the 
neuropeptide alpha-melanocyte stimulating hormone (αMSH). αMSH prevents cytotoxic T-cells from 
secreting inflammatory cytokines like interferon-gamma (IFN-γ) and interleukin-10 (IL-10),102 while 
promoting the induction of immunosuppressive regulatory T-cells.103 αMSH also inhibits neutrophil-
mediated lysing of corneal endothelial cells,101 and Toll-like receptor 4 (TLR4) signaling in 
macrophages.104 Secondary to αMSH in maintaining the immunosuppressive environment of the 
aqueous humor is the anti-inflammatory cytokine transforming growth factor-β2 (TGF-β2). TGF-β2 
has been identified as a potent immunosuppressive molecule of the aqueous humor,105 and thoroughly 
investigated for its regulation of T-cell proliferation, differentiation and survival in immune 
privileged microenvironments like the aqueous humor, as well as its suppression of NK activity106.  
Under normal conditions, these immunosuppressive cytokines and peptides ensure that 
leukocytes and lymphocytes entering the intraocular environment express their regulatory, anti-
inflammatory phenotypes. The trauma of surgery and introduction of a biomaterial, however, can 
disrupt the complex homeostatic processes that reinforce ocular immune privilege, leading to adverse 
biocompatibility outcomes like PCO. Diabetes mellitus can also cause a similar breakdown of the 
BAB that precedes the development of pathological diabetic conditions in the eye like diabetic 
retinopathy.107 Studies examining the cytokine composition of the aqueous humor in healthy and 
diabetic patients have demonstrated a number of key differences specifically involving pro-
inflammatory mediators. A comparison of the cytokine composition of the aqueous humor in healthy 
and a number of pathological states, including diabetes, post-cataract surgery and uveitis, is included 
below in Table 1.5. Uveitis is a state of inflammation of the uveal layer of the eye, caused by a failure 
of ocular immune privilege in response to infection or injury.108  
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Table 1.5: Summary of cytokine effect on inflammation and aqueous humor composition in 
healthy patients, in the post-phacoemulsification environment, during diabetic ocularpathy and 
during uveitis. 
Cytokine Inflammation In Health Post-Surgery Diabetes Uveitis 
αMSH Anti High    
IL-1β Pro Very Low ↑ ↑  
IL-1rα Anti Low    
IL-2 Pro Very Low   ↑ 
IL-4 Pro Very Low   
IL-5 Pro Very Low    
IL-6 Pro Low ↑ ↑ ↑ 
IL-7 Anti Very Low    
IL-8 Pro Low ↑ ↑ ↑ 
IL-9 Pro Very Low    
IL-10 Anti Very Low  ↓  
IL-12 Pro Low  ↓  
IL-13 Pro Very Low   ↑ 
IL-15 Pro Very Low    
IL-17 Pro None    
b-FGF Anti Low    
Eotaxin Pro Very Low    
G-CSF Pro None   ↑ 
GM-CSF Pro Low   ↑ 
IFN-γ Pro None   ↑ 
IP-10 Pro Very Low  ↑  
MCP-1 Pro High ↑ ↑ ↑ 
MIF Anti None    
MIP-1α Pro None   ↑ 
MIP-1β Pro High    
PDGF-BB Anti Very Low    
RANTES Pro Very Low   ↑ 
TGF-β2 Anti High    
TNF-α Pro None ↑  ↑ 
VEGF Anti High  ↑  
Information gathered on cytokines: in healthy populations,109 after phacoemulsification,110,111 in 
diabetics,109,112 and in uveitis.113,114 
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1.3.3.2 Posterior Capsule Opacification and Immune Privilege 
Following cataract surgery a disturbance of the BAB has been observed,115 either owing to 
mechanical injury sustained during the procedure or a selective lens epithelial cell response to 
trauma.110,116 Elevated levels of the pro-inflammatory cytokines monocyte chemoattractant protein-1 
(MCP-1), IL-8 and tumor necrosis factor-alpha (TNF-α) were observed in the post-operative aqueous 
humor for up to one year after surgery.110 As well, expression of MCP-1 was localized to proliferating 
lens epithelial cells in the capsular bag,110 providing evidence of a lens epithelial (or perhaps 
myofibroblast) recruitment of innate immune cells across a disturbed BAB. Given its name, MCP-1 
recruits monocytes and macrophages into active sites of trauma and inflammation; however, it also 
strongly influences T-cell activation and differentiation,117 providing a possible means for the 
induction of an adaptive and innate immune response to the trauma of cataract surgery. The question 
of what effect this selective deviation from immune privilege has on the development of PCO remains 
unanswered. Despite the well-established capability for selective recruitment of inflammatory cells 
across the BAB,97 leukocyte and lymphocyte ingress into the lens from the aqueous humor under 
healthy conditions appears to be unreported. This impenetrability by patrolling cells may be a result 
of the anti-proteolytic properties of the aqueous humor preventing a breakdown of the collagenous 
lens capsule combined with the tight-junction organization of the lens epithelium.118 However, since 
the barrier function of the lens capsule and epithelium are disturbed during surgical intervention, an 
avenue of entry for cells of the innate immune system does exist. 
1.4 Diabetes and Macrophage Biocompatibility 
Diabetic complications are increasingly believed to be caused by the pathological activation or 
inactivation of inflammatory processes in the human body.46 In the diabetic disease state, pathological 
changes to macrovascular and microvascular endothelial tissues induce further pathological changes 
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to the tissues being vascularized.46,119 The adverse behaviour of diabetic macrophages are increasingly 
well understood in the contexts of diabetic complications like impaired wound healing,120,121 
atherosclerosis,47,122–125 diabetic nephropathy,126–130 and diabetic retinopathy.131–133 Although 
avascularised, the lens can be compromised by what is called diabetic cataract,134 the pathogenesis of 
which is not well understood but believed to be a result of metabolic and oxidative damage in a high 
glucose environment.134–136 Similar to studies of IOL biocompatibility, little work has examined the 
possible role of macrophages in diabetic complications of the lens. 
Extensive work has demonstrated that impaired diabetic wound healing leads to worse 
biocompatibility outcomes in patients. The change in macrophage phenotype observed during 
diabetes mellitus prevents the resolution of the inflammatory phase in the diabetic wound healing 
response,50,121,137,138 causing a prolonged and more severe foreign body response. Meta-studies of 
dental implant survival have demonstrated higher rejection rates in diabetic subjects compared to non-
diabetic patients,139 and similar survival rates in those diabetic patients with excellent glycemic 
control.140,141 Similar observations were made for coronary stent implantation, with diabetic patients 
displaying a higher need for follow-up surgical intervention than non-diabetic patients.142 Differences 
in IOL biocompatibility have long been observed in diabetic patients. Interestingly, diabetic patients 
undergoing phacoemulsification experience a lower rate of PCO than non-diabetic patients after 3 
years.143 However, diabetics with PCO experience a more severe loss of vision,144 and experience 
higher rates of PCO with hydrophilic IOLs than non-diabetics with PCO.145 Additionally, the rate of 
calcification of hydrophilic IOLs appears to be higher in diabetic patients.146 Since the role of 
macrophages in impaired wound-healing and the foreign body response to implanted biomaterials are 
well understood, their unclear role in the lens warrants further investigation. 
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1.5 Thesis Objective and Outline 
The objective of this investigation was to further our understanding of the role of macrophages in the 
immune privileged environment of the inner eye. The evidence of macrophage participation in the 
development of PCO provides a good starting point for examining the interplay between lens 
epithelial cells and macrophages. If PCO is a fibrotic disease, macrophages likely play a role in its 
onset and development. Likewise, if diabetic lens pathology is similar to diabetic retinopathy, then 
macrophages likely play a role in the lens as well. As the first step, a novel in vitro co-culture system 
incorporating macrophages and lens epithelial cells in the same fluid environment was developed and 
detailed herein. In Chapter 2, the co-culture model was used to quantify – for the first time – 
macrophage activation to common IOL biomaterials, and the effect of this activation on lens 
epithelial cell phenotype.ii In Chapter 3, the effect of acute hyperglycemia on the co-culture model 
was investigated. In Chapter 4, the use of the co-culture model in biocompatibility testing and the 
next steps in development of the model are discussed.   
                                                     
ii A modified version of Chapter 2 has been accepted for publication by the Journal of Biomaterials Applications 
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Chapter 2 
Leukocyte Biocompatibility of IOL Materials and the Effect of 
Macrophage Activation on Lens Epithelial Cell Phenotype in vitro 
2.1 Introduction 
The widespread use of foldable IOLs in cataract surgery have reduced the size of incision necessary 
during phacoemulsification, reducing the extent of damage done to the corneal and uveal layers of the 
eye. Foldable IOLs are made from materials called hydrogels, defined as highly water-absorbent 
polymer networks. Although all hydrogels are internally hydrophilic, their surfaces may exhibit either 
hydrophilic or hydrophobic properties depending on their polymeric structure, as well as any 
chemical modifications made to the surface. The hydrogels and surface chemistries commonly used 
in IOL manufacturing include: (i) hydrophilic acrylic made of poly(2-hydroxyethyl methacrylate) (or 
pHEMA), (ii) hydrophobic acrylic based on poly(methyl methacrylate) (or PMMA), and (iii) 
hydrophobic silicone hydrogels. Older IOLs were made from a rigid composition of hydrophobic 
PMMA (acrylic glass) and still see regular use in many areas of the world.5 
Macrophages have been observed on the surface of IOLs explanted from human patients,86–89 
and animal models of PCO have suggested a role for macrophages in lens epithelial cell mobility,90  
during PCO, and therefore the severity of the disease. Studies examining the PCO incidence rate in 
vivo have noted a significantly lower rate of PCO in patients using IOLs with hydrophobic surfaces 
compared to hydrophilic surfaces of the same haptic design.83,91–93 Despite this, limited work has 
quantified the macrophage response to IOL materials and a possible effect on lens epithelial cell 
phenotype. Macrophages are well known to respond to hydrophobic and hydrophilic surfaces 
differently, with hydrophilic surfaces causing more pro-inflammatory activation than hydrophobic 
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ones.147–149 Uveal biocompatibility should therefore differ for hydrophilic and hydrophobic IOL 
materials. 
In this study, we hypothesized that IOL material-activated macrophages may secrete pro-
inflammatory cytokines and other mediators to induce a PCO-like phenotype in lens epithelial cells. 
Two biocompatibility outcomes were investigated: whether common IOL biomaterials could activate 
macrophages, and whether this activation could induce an inflammatory phenotype in lens epithelial 
cells. To examine the interplay between both cell populations, a tissue model of the post-operative 
lens system must therefore be developed. Systems biology is a modern approach to biological 
research that stands in contrast to reductionism: the traditional assumption that a system behaves as 
the sum of its parts. A system-level understanding requires knowledge of three properties: (1) the 
structure of the system, (2) the dynamics of the system, and (3) the control method of the system.150 
Any suitable design methodology should address all three aspects, or the aspects most in need of 
further examination. As the one-way effect of macrophage activation on lens epithelial cell phenotype 
is of interest, an in vitro model that incorporates both cell types (called a co-culture model) can be 
used to mechanistically supplement high-level animal studies of macrophage involvement in PCO. A 
better understanding of the role of macrophage activation in the post-operative lens will enable the 
development of more biocompatible IOL materials and further reduce the incidence rate of PCO. 
2.2 Materials and Methods 
2.2.1 Cell Culture 
A novel in vitro co-culture model of the post-operative lens environment was developed. The human 
acute monocytic leukemia cell line THP-1 (ATCC, Manassas, VA) was selected as the macrophage 
surrogate for its confirmed ability to produce macrophage secretory products.151 The SV-40 virus 
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immortalized human lens epithelial cell line HLE B-3 (ATCC) was used as the lens epithelial 
surrogate due to its widespread use in in vitro PCO studies.152–154  
2.2.1.1 Macrophage Culture 
THP-1 monocytes were cultured in RPMI 1640 cell culture medium (Invitrogen, Oakville, ON) 
supplemented with 10% fetal bovine serum (FBS; VWR, Mississauga, ON) and 0.9% 
penicillin/streptomycin (Invitrogen, Oakville, ON) and maintained in suspension at 5 x 105 cells/mL 
at 37°C and 5% CO2. THP-1 monocytes were differentiated into macrophages using the protein 
kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich, Oakville, ON), 
following an optimized protocol combining that of Park et al. and Daigneault et al.155,156. THP-1 
monocytes were seeded in 6-well tissue-culture polystyrene (TCPS) plates at a concentration of 5x105 
cells/well and treated with 5 nM PMA for 72 hours. THP-1 cells were inspected after 24 and 48 hours 
for adherence and viability. At 72 hours, media was replaced without PMA, and the adherent THP-1 
cells were allowed to rest for 48 hours. Media was replaced once again and the THP-1 macrophages 
were allowed to rest for a further 48 hours. Figure 2.1 shows macrophage-like cell phenotype 
throughout the differentiation process. 
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Figure 2.1: Macrophage differentiation progress. Images taken at 40x with visual field 
microscope after: (a) 72 hour treatment with PMA, (b) 48 hour rest in PMA-free media, (c) 
additional 48 hour rest. 
To prepare for co-culture, mature differentiated macrophages were washed twice with room 
temperature phosphate-buffered saline (PBS) for 5 minutes and disassociated by incubation with 
TrypLETM Express (Invitrogen, Oakville, ON) for 20 minutes at 37°C. Cells were centrifuged in 
RPMI 1640 media with 10% FBS, re-suspended in fresh media and transferred to the co-culture plate. 
2.2.1.2 Lens Epithelial Cell Culture 
HLE B-3 were cultured in Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen, Oakville, ON) 
supplemented with 10% FBS and 0.9% penicillin/streptomycin and maintained at 37.0°C in 5% CO2. 
To prepare for co-culture, cells were serum starved for 24 hours60. Serum starvation allows cells to 
recover signalling pathways to baseline levels of activity, where cytokines and signalling molecules 
in serum may have induced an effect.130,157,158 Cells were dissociated from a flask with TrypLE 
Express and then centrifuged in serum-free DMEM. 
(a) (b) (c)
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To begin co-culture, 24-well polyethylene terephthalate 1-µm membrane hanging cell-culture 
inserts (EMD Millipore, Billerica, MA) were inverted in a 6 well plate, and 5 x 104 HLE B-3 cells 
were seeded onto the superior surface. Inserts were incubated overnight to allow for strong cellular 
adherence, and then returned to their normal orientation in serum-free media in a 24-well plate (EMD 
Millipore) until the start of the co-culture. 
2.2.2 IOL Preparation 
Commercially available, surgical-grade PMMA and pHEMA IOLs were purchased from Freedom 
Ophthalmic (Mississauga, ON) in both square and round-edged designs. To prepare for culture, the 
IOLs were incubated in RPMI 1640 with 10% FBS for 2 hours to allow for protein adsorption, 
specifically albumin and fibronectin.82 Manufacturer information pertaining to the IOLs used in the 
co-culture system are included below in Table 2.1. 
Table 2.1: IOL designs used in co-culture system 
Model PCC 503 PMC 533SQ HFC 603 AFC 603SQ 
Material PMMA PMMA poly-HEMA poly-HEMA 
Optic Design Equiconvex Equiconvex Equiconvex Equiconvex 
Optic Size 5.00 mm 5.50 mm 6.00 mm 6.00 mm 
Overall Length 12.50 mm 12.50 mm 12.50 mm 12.50 mm 
Haptic Angle Cap.C step vault Mod.C step vault 0’ 0’ 
Dialing Holes - - - - 
A.Constant 118.4 118.4 118.0 118.0 
AC Depth 5.00 mm 5.00 mm 5.00 mm 5.00 mm 
 
2.2.3 Co-culture 
The co-culture system diagram is shown in Figure 2.2. Prepared IOLs were transferred into fresh 
wells of a 24-well Millipore plate in RPMI containing 10% FBS. Disassociated mature THP-1 
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macrophages were then seeded at 1 x 105 cells/well. Plates were incubated for 2 hours to allow for 
macrophage adherence. Hanging inserts with adherent HLE cells were then introduced to the wells 
containing one of the following: macrophages and an IOL (treatment), macrophages and no IOL 
(control), no macrophages and an IOL, or no macrophages and no IOL. Co-culture plates were 
incubated for either 1, 2, 4 or 6 days before analysis. Media was replaced every 2 days. 
 
Figure 2.2: Co-culture system diagram. Inserts are inverted and lens cells are seeded on the 
superior surface before being returned to their normal orientation in a well containing 
adherent macrophages and an IOL. 
 
2.2.4 Immunolabelling Reagents 
Fluorescein isothiocyanate (FITC) conjugated mouse monoclonal antibody against CD36 (multi-
ligand scavenger receptor), R-phycoerythrin-cytochrome 5 (PE-Cy5) conjugated monoclonal 
antibody against CD45 (human leukocyte common antigen), R-phycoerythrin (PE) conjugated 
monoclonal antibody against CD54 (intercellular adhesion molecule 1 or ICAM1), PE conjugated 
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mouse monoclonal antibody against CD14 (pattern recognition receptor), Alexa Fluor® 647 (AF647) 
conjugated mouse monoclonal antibody against E-cadherin, and PE conjugated polyclonal antibody 
against rabbit IgG produced in donkey were purchased from Becton Dickinson Pharmingen (San 
Diego, CA, USA). Monoclonal rabbit antibody against fibronectin, and FITC conjugated mouse 
monoclonal antibody against α-smooth muscle actin (α-SMA) were purchased from Sigma-Aldrich. 
All other chemicals were of analytical reagent grade. 
2.2.5 Flow Cytometry 
Upon completion of the co-culture, inserts with adherent HLE cells were removed from the co-culture 
system. Wells containing macrophages were incubated at 37°C with TrypLE Express for 45 minutes. 
THP-1 cells were then centrifuged in media containing 10% FBS and re-suspended in 100 µL fresh 
media with serum. Aliquots of 50 µL were incubated in saturating concentrations of conjugated 
fluorescent monoclonal antibodies for 1 hour at room temperature in the dark. Leukocyte populations 
were identified by adding anti-CD45 antibody to all samples. To assess macrophage activation, 
samples were incubated with anti-CD54 or anti-CD14 antibody, as well as anti-CD36 antibody. After 
incubation, samples were diluted with HEPES-Tyrode’s buﬀer (HTB: 137 mM NaCl, 2.7 mM KCl, 5 
mM MgCl2, 3.5 mM HEPES, 1 g/L Glucose, and 2 g/L BSA, PH 7.4) and fixed with 
paraformaldehyde (final concentration of 1% w/v). Samples were read on a three-color FACSCalibur 
ﬂow cytometer (Becton Dickinson). 
To assess intracellular ROS/RNS production, macrophages were cultured with or without an 
IOL for 24 hours. Macrophages on the IOL surface were dissociated separately from those on the 
TCPS surface. After centrifugation, samples were incubated in serum-free media containing 100 μM 
of 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) (Invitrogen) for 30 minutes at 37°C in the 
dark. Cells were read immediately on a three-color FACSCalibur ﬂow cytometer. Samples were 
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analysed to completion. Cell counts for adherent macrophage on each IOL were performed in 
CellQuest Pro (BD) by distinguishing single cells from subcellular debris on the basis of size and 
granularity, estimated by forward scatter and side scatter respectively. 
Inserts with adherent HLE cells were submerged in 0.25% Trypsin-EDTA (Invitrogen) and 
incubated at 37°C for 2 hours on a shaker at 250 RPM. Once detached, cells were re-suspended in 
DMEM with 10% FBS before centrifugation. Excess media was removed. Cells were re-suspended 
and then fixed in paraformaldehyde at a final concentration of 4% w/v for 15 minutes, at room 
temperature in the dark. Samples were washed, and cells were re-suspended and permeabalized with 
0.5% Triton-X (Sigma-Aldrich) for 5 minutes, at room temperature in the dark. Samples were then 
centrifuged and re-suspended in PBS containing 1% w/v fatty-acid free bovine serum albumin (BSA; 
EMD Millipore). Samples were separated into three aliquots and stained with antibodies against 
either α-SMA (FITC conjugated), E-cadherin (AF647 conjugated) or fibronectin overnight, at 4°C in 
the dark. The following morning, samples containing anti-fibronectin were labelled with PE anti-
rabbit IgG secondary antibody for 1 hour, at room temperature in the dark. Samples were read 
immediately on a three-color FACSCalibur ﬂow cytometer (Becton Dickinson). 
2.2.6 Confocal Microscopy 
Confocal microscopy was used to confirm the phenotype of the lens epithelial cells, as well as to 
determine macrophage adherence to each IOL material. To serve as a positive control, some HLE 
cells were cultured without macrophages and treated with 5 ng/mL of TGF-β2 (Sigma-Aldrich) for 2 
days prior to imaging. To serve as a negative control, HLE cells were cultured without macrophages 
for 6 days and not exposed to any other treatment. 
Adherent HLE cells on the insert were washed twice with room-temperature PBS for 5 
minutes. Cells were fixed in paraformaldehyde at a final concentration of 4% w/v for 15 minutes, 
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washed once with PBS, and then permeabalized with 0.5% Triton-X in PBS for 5 minutes in the 
dark152. Cells were washed with PBS, and then stained overnight in 1% BSA in PBS with antibodies 
for α-SMA, fibronectin or E-cadherin at 4°C in the dark. For the samples labelled with anti-
fibronectin, secondary antibody was added after washing with PBS and the samples were incubated 
for one hour at room temperature in the dark. Samples were washed with PBS at room temperature 
and then imaged by an inverted laser scanning confocal microscope (LSM 510 Meta, Carl Zeiss, 
Germany) using an argon laser (488 nm excitation) and HeNe laser (543 nm and 633 nm excitation). 
IOLs were removed from the co-culture model and fixed in 4% paraformaldehyde for one hour. To 
confirm the presence of adherent macrophages on the IOLs, samples were blocked with 1% BSA in 
PBS and then incubated with saturating concentrations of fluorescently labelled antibodies against 
CD36, CD54 or CD14, and CD45 overnight at 4°C in the dark. The following morning, samples were 
rinsed in PBS and imaged by an inverted laser scanning confocal microscope (LSM 510 Meta, Carl 
Zeiss, Germany) using an argon laser (488 nm excitation) and HeNe laser (543 nm and 633 nm 
excitation). 
2.2.7 Statistical Analysis 
Flow cytometry fluorescence values are presented as the mean ± the standard error of the mean 
(SEM). Fluorescence values and fluorescence-ratios were subjected to a multivariate analysis of 
variance (ANOVA) using a general linear model, including terms for length of incubation, lens 
material, and when applicable, the presence or lack of macrophages in the co-culture. Pairwise 
comparisons between materials, incubation times, and material-time combinations were performed 
using the Bonferoni criterion in Minitab 16.2.3 (State College, PA, USA). A p value of less than 0.05 
was required for significance. The number of experiments was always equal to or greater than three. 
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2.3 Results 
2.3.1 Macrophages increase α-SMA expression in lens epithelial cells 
The novel co-culture model was employed to examine the possible effect of macrophages on lens 
epithelial cells. As illustrated in Figure 2.3, after a 6-day incubation, both the presence of 
macrophages and an IOL material were required to significantly (p < 0.03) affect the expression of 
the myofibroblast protein α-SMA in lens epithelial cells. In the lens cell mono-culture, the presence 
of an IOL alone had no effect on α-SMA expression (p > 0.59); note that in our in vitro model, the 
lens cells are not in physical contact with the lenses. In the absence of an IOL, the presence of 
macrophages in the co-culture model induced a small but significant increase in α-SMA expression (p 
< 0.031). Co-culture with pHEMA IOLs induced a significant upregulation of α-SMA in lens 
epithelial cells when compared to both lens cell mono-culture with pHEMA IOLs (p < 0.033) and co-
culture with no IOL (p < 0.007). Similarly, co-culture with PMMA IOLs induced a significant 
upregulation of α-SMA when compared to the lens cell mono-culture with PMMA IOLs (p < 0.02), 
but this upregulation was not statistically significant when compared to co-culture with no IOL (p < 
0.08). Neither 2 nor 4 days of co-culture provided the required length of time to detect differences in 
the expression of α-SMA in lens cells. 
  31 
 
Figure 2.3: Co-culture with macrophages increases expression of α-SMA in HLE B-3 cells 
versus cells in a mono-culture. All cells were cultured for 6 days. α-SMA expression was 
measured by flow cytometry and is reported as the mean of arbitrary fluorescence units (AFU). 
* indicates significant difference from respective α-SMA expression observed in lens cells in 
monoculture (no macrophages) (p < 0.031); ** significant difference (p < 0.01). n = 4 for all 
treatments and controls. 
 
As shown in Table 2.2, no significant difference in fibronectin expression in co-cultured lens 
cells was induced by the presence of an IOL material. However, fibronectin expression significantly 
decreased between 2 and 4 days of co-culture (p < 0.0008) with a PMMA IOL, and between 4 and 6 
days of co-culture with no IOL (p < 0.003). Similarly, no significant difference in E-cadherin 
expression was induced by the presence of an IOL material. However, E-cadherin expression was 
significantly upregulated (p < 0.03) after 6 days of co-culture with a pHEMA IOL compared to E-
cadherin expression at both 2 days and 4 days. 
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Table 2.2: Fibronectin and E-cadherin expression on lens epithelial cells cultured for 2, 4, or 6 
days with a PMMA lens, pHEMA lens or no lens. Protein expression was measured by flow 
cytometry and is reported as the geometric mean of arbitrary fluorescence units (AFU) ± the 
standard error of measurement (SEM). 
 
IOL Material Incubation Time Fibronectin E-cadherin 
No material 2 days 34 ± 8 13 ± 1 
 4 days 22 ± 5 12 ± 3 
 6 days 18 ± 6* 14 ± 1 
PMMA 2 days 35 ± 5 13 ± 1 
 4 days 22 ± 4+ 13 ± 2 
 6 days 21 ± 7+ 14 ± 1 
pHEMA 2 days 29 ± 4 12 ± 1 
 4 days 23 ± 4 13 ± 2 
 6 days 21 ± 7 15 ± 1‡ 
 
n = 7 at 2 days, and n = 4 at both 4 days and 6 days. 
* Significantly different from corresponding value at 2 days (p < 0.003). 
+ Significantly different from corresponding value at 2 days (p < 0.0008). 
‡ Significantly different from corresponding value at 2 days (p < 0.00001) and 4 days (p < 0.03). 
Differences in α-SMA expression observed in flow cytometry were confirmed by confocal 
microscopy. For comparison purposes, treatment with 5 ng/mL of TGF-β2 for 2 days was included as 
a positive control, and lens cell mono-culture included as a negative control. As illustrated in Figure 
2.4, high levels of α-SMA expression (shown in green) were observed for the TGF-β2, co-culture with 
pHEMA IOLs and co-culture with PMMA IOLs groups (Figure 2.4a, 3b and 3c respectively). Co-
culture in the absence of an IOL resulted in a reduced expression of α-SMA (Figure 2.4d) and lens 
cell mono-culture (Figure 2.4e) showed the weakest staining for α-SMA. Regardless of incubation 
conditions expression of E-cadherin (shown in red) was similar, with significant background staining 
on all PET substrates. 
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Figure 2.4: HLE B-3 cells imaged at 40x zoom using a confocal laser scanning microscope. Scale 
bar represents 50 µm. Left (green): stained for α-SMA. Right (red): stained for E-cadherin. (a) 
Mono-culture with 5 ng/mL of TGF-β2 for 2 days; positive control. (b) Co-culture with pHEMA 
IOL for 6 days. (c) Co-culture with PMMA IOL for 6 days. (d) Co-culture with no IOL for 6 
days. (e) Mono-culture with no IOL for 6 days; negative control. Images are representative of 
triplicate of each treatment category. 
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2.3.2 Macrophages upregulate CD54 expression in response to pHEMA lenses 
Macrophage activation induced by the presence of IOL materials was characterized over 6 days. 
Upregulated cell-surface CD54 receptor expression was observed at 2 days, 4 days and 6 days of 
incubation. As shown in Figure 2.5, after 2 days of incubation, macrophages cultured with a pHEMA 
lens significantly upregulated CD54 expression relative to cells cultured with no lens (p < 0.03), but 
not compared to the expression on cells cultured with PMMA lens (p < 0.117). CD54 expression 
decreased significantly after 2 days (p < 0.0001) and remained approximately constant between 4 and 
6 days incubation (Figure 2.5). The presence of a PMMA lens did not result in a significant 
upregulation of CD54 when compared to control (macrophages with no IOL, p = 1.0). 
 
Figure 2.5: CD54 cell-surface receptor expression on macrophages cultured for 2, 4 or 6 days 
with a PMMA lens, pHEMA lens, or no lens. CD54 expression was measured by flow cytometry 
and is reported as the mean of arbitrary fluorescence units (AFU). * indicates a significant 
difference of p < 0.03. n = 7 at 2 days and n = 4 at both 4 and 6 days. 
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Cell-surface expression of CD45, the human leukocyte common antigen, and CD36, the 
thrombospondin receptor, were not affected by the presence of an IOL material (Table 2.3). However, 
for all samples, expression of both receptors on macrophages appeared to decrease over time: CD45 
expression was significantly decreased at 6 days when compared to both 2 and 4 days (p < 0.01), 
while significantly decreased expression of CD36 was observed at 4 and 6 days when compared to 2 
days (p < 0.0001). As for the expression of the lipopolysaccharide receptor CD14, the presence of an 
IOL material induced no changes in expression. However, CD14 expression was down-regulated at 6 
days relative to both 2 days and 4 days (p < 0.02). 
Table 2.3: CD45, CD36 and CD14 cell-surface receptor expression on macrophages cultured for 
2, 4, or 6 days with a PMMA lens, pHEMA lens or no lens. Receptor expression was measured 
by flow cytometry and is reported as the geometric mean of arbitrary fluorescence units (AFU) 
± the standard error of measurement. 
 
IOL material Incubation time     CD45     CD36     CD14 
No material 2 days 57 ± 13 26 ± 6 17 ± 5 
 4 days 57 ± 12 16 ± 8* 24 ± 6 
 6 days 38 ± 9*+ 17 ± 7* 15 ± 4+ 
PMMA 2 days 58 ± 6 26 ± 4 22 ± 5 
 4 days 54 ± 9 16 ± 5* 21 ± 2 
 6 days 38 ± 6*+ 14 ± 8* 15 ± 2+ 
pHEMA 2 days 54 ± 6 23 ± 4 19 ± 4 
 4 days 64 ± 8 19 ± 6* 26 ± 4 
 6 days 40 ± 6*+ 15 ± 6* 17 ± 3+ 
n = 7 at 2 days, and n = 4 at both 4 days and 6 days. 
* Significantly different from corresponding value at 2 days (p < 0.01). 
+ Significantly different from corresponding value at 4 days (p < 0.02). 
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2.3.3 pHEMA surfaces prevent strong macrophage adhesion 
The relationship between CD54 upregulation and macrophage adhesion to IOL materials was 
investigated using confocal microscopy. After 2 days of incubation the surface of the pHEMA IOL 
was devoid of macrophages, as determined by immunostaining for CD45. Instead, the surface was 
covered in CD45+/CD54+ microparticles of two forms: a sharp, jagged appearance that stained 
strongly for CD54 (* in Figure 2.6a), and a granular appearance that stained less strongly for CD54 (‡ 
in Figure 2.6b). Also found infrequently on the surface were larger, cell-sized impressions staining 
positively for CD54 and CD45 (+ in Figure 2.6a). These impressions lacked the three-dimensional 
geometry of macrophages and instead appeared as a thin film on the IOL surface. A pHEMA lens 
cultured without macrophages and treated with the same staining protocol served as a negative 
control for the binding of CD45 and CD54 (Figure 2.6c), confirming specific binding of the 
fluorescent antibodies. 
In contrast, many hundreds of CD45+ macrophages but very few microparticles were found 
on the hydrophobic surface of the PMMA IOL after 2 days of incubation time. These cells stained 
very strongly for CD54, and took one of three appearances. First observed were giant, circular cells of 
diameter greater than 100 µm, as shown in Figure 2.7a. These cells were multinucleated and 
resembled foreign body giant cells (FBGCs). Also observed were macrophages with pseudopodia 
extended, often times joining the body of other macrophages, as shown in Figure 2.7d. These cells 
were typically around 250 µm in length, varying in width along their length. Lastly were globular 
macrophages with sharp cytoplasmic projections that extended in all directions, as shown in Figure 
2.7c and Figure 2.7d. These cells varied in size between 30 µm and 60 µm in diameter, and were the 
most common adherent cells observed on the hydrophobic PMMA IOL surface. 
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Figure 2.6: The surface of a pHEMA IOL observed on a confocal laser scanning microscope 
with a 40x objective. Scale bar represents 50 µm. Images (a) and (b) show a lens cultured with 
macrophages for 2 days and then stained with anti-CD54 (shown in yellow) prior to imaging. 
Both images depict different sections of the same IOL, and are representative of three samples. 
Image (c) depicts a lens cultured without macrophages, stained for CD54 and CD45, included as 
a negative control. + indicates a large, cell-sized impression staining positive for CD54 and 
CD45. ‡ indicates granular microparticles staining weakly for CD54 and CD45. * indicates 
jagged microparticles staining strongly for CD54 and CD45. 
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Figure 2.7: The surface of two PMMA IOLs imaged with a confocal laser scanning microscope 
on a 40x objective. Scale bar represents 50 µm. Lenses were cultured with macrophages for 48 
hours and then stained with anti-CD54 (shown in yellow) prior to imaging. (a) depicts a 
multinucleated FBGC. (c) and (d) depict smaller macrophages with sharp cytoplasmic 
projections. (b) and (d) depict macrophages with elongated pseudopodia. Images are a 
representative area of at least 3 different IOLs studied. 
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2.3.4 Oxidative species are generated in response to PMMA and pHEMA lenses 
ROS and RNS generation have been implicated in the development of a number of inflammatory 
disorders30. ROS/RNS production and overall oxidative stress, assessed by DCF fluorescence, was 
measured in macrophages adhered to the IOL as well as those adhered to the tissue-culture plate after 
one day of incubation. This incubation length was chosen as a result of the confocal study, where the 
absence of strongly-adherent macrophages on pHEMA IOLs at 2 days of incubation was observed. 
As shown in Figure 2.8, incubation in the presence of either a PMMA or pHEMA IOL caused a 
significant increase in production of ROS/RNS in macrophages adherent to the TCPS surface (p  < 
0.03) compared to control macrophages (no IOL). Furthermore, macrophages on the PMMA or 
pHEMA IOL surface exhibited significantly lower DCF fluorescence when compared to both control 
macrophages (no IOL) (p < 0.004) and macrophages that remained on TCPS (p < 0.0001). 
 
Figure 2.8: ROS/RNS production in macrophages cultured for 24 hours with a PMMA or 
pHEMA IOL. Macrophage adhered to the IOL were treated separately from those on the tissue 
culture plate (TCPS) surrounding the IOL. Values presented are DCF fluorescence measured 
by flow cytometry and normalized to control DCF fluorescence (no IOL). * indicates (p < 0.03); 
** indicates (p < 0.004); *** indicates (p < 0.0001). n = 6 for all treatments. 
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To examine the capability of macrophages to adhere to each IOL material after one day of 
incubation, adherent macrophage were dissociated and counted using a flow cytometer. The 
hydrophilic surface of the pHEMA IOL had fewer adherent cells at 1 day (1773 ± 844) than the 
hydrophobic surface of the PMMA IOL (3376 ± 1367), however this difference did not reach 
statistical significance (p < 0.07, n = 6). 
2.4 Discussion 
Upon exposure to the protein kinase C activator PMA, the human monocytic leukemia cell line THP-
1 differentiate into macrophage-like cells that resemble native monocyte-derived-macrophages in 
morphology,159 phagocytic ability, cell-surface receptor expression and cytokine/chemokine 
production.151,156,160,161 Owing to this, THP-1 macrophages have been used extensively to investigate 
material biocompatibility in vitro.162–165 Further work has optimized THP-1 differentiation protocols 
to ensure sensitivity to weak stimuli,155 and a high phenotypic similarity to native macrophages,156 
combined for the first time in the present study. The SV-40 virus immortalized human lens epithelial 
cell line HLE B-3 was selected for use in the co-culture model. Although differences between the 
proteomes of native lens epithelial cells and HLE B-3 have been investigated, namely the absence of 
crystallin protein expression in HLE B-3,166 the cell line continues to be used extensively to study 
signalling pathways and mechanisms in PCO,60,63,64,152,153,167 and capsular biocompatibility with IOL 
materials.168,169 
Our objective was to examine the uveal biocompatibility of PMMA and pHEMA IOL 
materials by quantifying cellular activation. To measure activation, we chose to examine expression 
of the cell-surface adhesion protein CD54 (or ICAM-1) on macrophages in vitro. CD54 has been 
shown extensively in the literature to be upregulated on macrophages in response to inflammatory 
stimuli (see Roebuck et. al,51 Sheikh et. al 52). Specifically, Imanaka et. al observed a strong 
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correlation in vivo between CD54 upregulation and increased production of TGF-β1,54 and Koyama 
et. al reported that CD54 activity functioned as a signal transducer for IL-1β gene transcription in 
vitro.53 Following 2 days exposure to an IOL, we observed significant increases in expression of 
CD54 on macrophages cultured with a hydrophilic acrylic (pHEMA) IOL compared to cells cultured 
on TCPS, as well as cells cultured with a hydrophilic acrylic (PMMA) IOL, suggesting that 
hydrophilic acrylic materials may cause significant macrophage activation compared to hydrophobic 
acrylic materials. This observation is in agreement with previous work by Anderson and Jones who 
reported significant levels of macrophage activation to hydrophilic polyacrylamide (PAAm) surfaces 
compared to hydrophobic poly(styrene-co-benzyl N,N-dimethyldithio-carbamate) (BDETDC) 
surfaces, resulting in significantly increased production of IL-10, IL-1β, IL-6 and MIP-1β.79 They 
concluded that a strong inverse relationship exists between macrophage adhesion and macrophage 
activation. A similar inverse relationship was observed in the present study; macrophages exposed to 
a pHEMA IOL showed signs of significant activation but an inability to strongly adhere to the IOL 
surface. Differences in CD54 expression between the hydrophobic PMMA IOL and TCPS were 
insignificant, corroborating work by Bernatchez et. al wherein no CD54 upregulation was observed 
with peritoneal macrophages cultured on hydrophobic polylactic acid surfaces versus TCPS.170 Our 
results appear to agree with previous work investigating hydrophobic and hydrophilic materials, 
further suggesting that differentiated THP-1 macrophages represent a good model of macrophage 
biocompatibility. 
The scavenger receptor CD36 plays a crucial role in the phagocytosis of apoptotic cells,171–173 
although little evidence supports inducible expression by biomaterials. We observed no effect on the 
expression of CD36 by the inclusion of an IOL, but detected a reduction in CD36 expression after 2 
days of culture. Draude and Lorenz reported that exposure to the wound-healing cytokine TGF-β1 
supressed CD36 expression on macrophages,174 indicating a possible macrophage phenotypic shift in 
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the present study. The pattern recognition receptor CD14 plays a role in the phagocytosis of both 
apoptotic cells,175 and bacterial and viral pathogens,58 but is typically used as a marker of monocyte 
differentiation into macrophages.176,177 We observed no effect on the expression of CD14 by the 
inclusion of an IOL, but identified a decrease in CD14 expression by 6 days of macrophage culture. 
Bosshart et. al observed a spontaneous decrease in CD14 expression in blood-isolated monocytes ex 
vivo, indicating a quiescent state capable of rapid reactivation upon lipopolysaccharide stimulation.178 
Kindlund et. al concluded that CD14 down-regulation occurred during the differentiation process 
from monocyte to osteoclast.179 Also observed in the present study was a reduction in CD45 
expression after 4 days of culture, perhaps indicating a change in macrophage activity to a more 
quiescent state.180 In their work examining the macrophage response to biomaterial surface chemistry, 
Anderson and Jones noted a phenotypic change after 3 days of macrophage culture that resembled a 
shift from a host-defence phenotype to a wound-healing phenotype.79 This shift to a less 
inflammatory state may have been echoed in the present study by the decrease in expression of CD36, 
CD14 and CD45 observed after 4 days of macrophage culture.  
ROS and RNS are important signalling molecules in a number of inflammatory processes and 
disorders.30 To analyze the acute inflammatory response of macrophages to hydrophobic and 
hydrophilic IOL materials, ROS/RNS production and overall oxidative stress were measured using 
the probe DCFH-DA. Due to the fact that very few cells were found adherent to the pHEMA IOLs at 
2 days of incubation, ROS/RNS generation was quantified after one day of culture. After exposure to 
either the hydrophobic PMMA or hydrophilic pHEMA IOL we observed an increase of ROS/RNS 
production in macrophages on the TCPS substrate compared to macrophages not exposed to an IOL. 
This finding coincides with but cannot be correlated with the increased expression of CD54 after 2 
days of culture with either IOL material. Iribarren et. al noted a similar correlation in vivo between 
increased ROS generation and CD54 upregulation.55 However, we observed significantly less 
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ROS/RNS production in macrophages on the surface of either IOL compared to macrophages on the 
TCPS substrate surrounding the IOL, as well as macrophages not exposed to an IOL. The DCFH-DA 
probe is a membrane-permeable fluorogenic compound that is de-acetylated by cytosolic esterases 
into the membrane-impermeable 2’-7’-dichlorodihydrofluorescein (DCFH2).181 Once trapped inside 
the cell, DCFH2 is oxidized by peroxidases, cytochrome c and Fe2+ in the presence of intracellular 
hydrogen peroxide, producing the fluorescent compound 2’-7’-dichlorofluorescein (DCF).182 
Brubacher and Bols showed that the DCFH-DA probe underestimated ROS production in 
macrophages due to either low esterase expression or a sequestering of esterase into inaccessible 
cellular compartments,183 a conclusion made previously by Robinson et. al.184 Labow et. al showed 
previously that monocyte-derived macrophages secrete a number of esterases to degrade biomaterial 
surfaces,185 a process known as frustrated phagocytosis.186 In the present study, it is likely that the 
compartmentalization and secretion of cellular esterases led to an underestimation of oxidative stress 
in macrophages adherent to the IOL surfaces.  
Using confocal microscopy, the number and phenotypic appearance of adherent macrophages 
on each biomaterial surface was investigated in vitro. Ziegelaar et. al previously reported that THP-1 
cells showed decreased adherence to pHEMA surfaces compared to TCPS and noted a relationship 
between adhesion and collagenase production,162 but did not normalize for the number of adherent 
cells. In the present study, fewer cells were found adhered to the pHEMA IOLs than the PMMA IOLs 
despite what appears to be significant macrophage activation. After one day of incubation, 
approximately half as many macrophages were counted via flow cytometry on the pHEMA surface 
compared to the PMMA surface. After 2 days of incubation, the PMMA surface showed signs of 
FBGC fusion while the pHEMA IOL was devoid of cells. Macrophages were instead found on the 
TCPS substrate surrounding the pHEMA IOL for up to 6 days of culture. Macrophages were found 
loosely adherent to the pHEMA IOL surface after 1 day exposure but were no longer present at 2 
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days incubation. Rice et. al observed the migration of primary osteoblasts from titanium oxide 
surfaces to exposed TCPS surfaces in vitro during a 7 day period,187 and thus a similar migration may 
have occurred. Furthermore, CD45+/CD54+ impressions of detached cells and microparticles were 
found on the surface of the pHEMA lens at 2 days incubation. Macrophage microparticles were 
observed by Cerri et. al to upregulate inflammatory processes in human airway endothelial cells.188 
Gauley et. al observed that Toll-like-receptor stimulation of macrophages lead to microparticle 
release; a process influenced by ROS production.189 These findings suggest that the microparticles 
observed on the pHEMA surface, as well as the changes in ROS/RNS production, may mediate the 
response of lens epithelial cells in the co-culture. While many studies have characterized macrophage 
adhesion on biomaterials, there is limited work reporting on the adherence of macrophage 
microparticles on biomaterial surfaces, perhaps owing to the limited use of confocal microscopy for 
macrophage markers on implant surfaces. Although the pHEMA lens surface prevented adherence, in 
the post-operative in vivo environment, the newly-exposed collagen-IV rich anterior lens capsule may 
serve as a substrate for macrophage adherence in patients with pHEMA IOLs. On the other hand, the 
PMMA lens allowed for strong adherence of macrophages and enabled fusion into what appeared to 
be multi-nucleated FBGCs. Similar to our in vitro results, Ravalico et. al observed significant 
inflammatory cell adhesion and fusion on PMMA lenses in human patients between 7 and 180 days 
after corrective surgery for cataracts, with a corresponding lack of cellular adhesion and fusion on 
pHEMA lenses.190  
During the development of PCO, myofibroblasts in the lens capsule overexpress the 
extracellular matrix protein fibronectin and halt expression of the epithelial adhesion protein E-
cadherin.22 Chung et. al showed that treatment with TGF-β1 induced fibronectin expression in HLE 
B-3 cells,152 while Hosler et. al showed that treatment with TGF-β2 induced fibronectin gene 
activation in HLE B-3 and primary cells.64 Choi et. al observed that TGF-β1 treatment repressed E-
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cadherin expression in HLE B-3 cells,60 while a similar study by Yao et. al observed the same finding 
but in alveolar epithelial cells.191 In the present study, no difference in fibronectin or E-cadherin 
expression was induced by lens cell and macrophage co-culture with an IOL material. These findings 
may indicate that the TGF-β family of cytokines may not participate in the interaction between co-
cultured macrophages and lens epithelial cells. Indeed, an enzyme-linked immunosorbent assay 
(ELISA) for TGF-β1 was performed on co-culture and activated-macrophage supernatants to examine 
a possible effect, but TGF-β1 was observed at background levels. In light of these findings, it seems 
probable that another soluble mediator is responsible for the observed interaction. 
The novel in vitro co-culture model presented herein incorporated lens epithelial cells and 
macrophages on separate substrates in the same media environment. Similar co-culture models have 
demonstrated the ability of macrophages to promote inflammation in hepatocytes and 
adipocytes,151,192,193 stimulate bone resorption,194 direct apoptosis and suppress cell division in 
mesangial cells.195 More relevant to this investigation, Glim et. al demonstrated that M2 (wound-
healing) macrophages induced the expression of the myofibroblast protein and secondary-cataract 
marker α-SMA in dermal and gingival fibroblasts via the secretion of platelet derived growth 
factor.196 After 6 days of co-culture with macrophages activated by a pHEMA IOL, lens epithelial 
cells significantly increased expression of α-SMA relative to co-culture with no IOL, as demonstrated 
both by flow cytometry and confocal microscopy. α-SMA expression has been shown to increase 
contractile force in fibroblasts197, and Lois et. al observed a reduction in the number of lens epithelial 
cells in the center of the posterior capsule after systemic macrophage depletion,90 indicating a 
possible role for macrophage activation to IOL biomaterials in the severity of posterior capsule 
wrinkling during PCO. Anderson and Jones noted that macrophages cultured on hydrophilic PAAm 
surfaces produced greater quantities of inflammatory cytokines than macrophages cultured on 
hydrophobic BDETDC despite being substantially fewer in number,79 concluding that total volume of 
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cytokine production was a function of the number of activated cells and the degree to which they 
were activated. In the present study, macrophages cultured on a hydrophilic pHEMA surface were 
significantly more activated and fewer in number than macrophages cultured on a hydrophobic 
PMMA surface. However, both groups induced approximately the same upregulation of α-SMA in 
co-cultured lens cells, lending further evidence to the hypothesis that the gross foreign body reaction 
to a biomaterial is a function of both the numbers and degree of macrophage activation. 
2.5 Conclusions 
Our findings provide a novel insight into uveal biocompatibility. Previous work exploring IOL 
biocompatibility with inflammatory cells have based their conclusions on the number of leukocytes 
adherent to a given material, concluding that hydrophilic surfaces that prevent cellular adhesion are 
more biocompatible with leukocytes as they prevent fusion into FBGCs.83–85 Our results have shown 
in vitro that FBGC formation, and indeed macrophage adherence in general, are not necessary for a 
strong inflammatory response to an IOL. Rather, the inflammatory response to an IOL appears to be a 
function of both the amount of stimulation and the number of inflammatory cells stimulated, with a 
hydrophilic acrylic surface providing a stronger stimulus for macrophage activation than a 
hydrophobic acrylic one. These findings provide a new method of inquiry into uveal biocompatibility, 
specifically through the quantification of cell-surface markers of leukocyte activation. 
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Chapter 3 
The Effect of Elevated Glucose Levels on the Co-culture System 
3.1 Introduction 
Diabetes mellitus is a family of diseases characterized by an inability to regulate blood glucose levels, 
resulting in prolonged periods of high blood sugar called hyperglycemia that cause damage to vital 
tissues of the human body.46,119,123,125,198–204 Diabetes typically manifests as one of two chronic 
illnesses: Type 1 Diabetes Mellitus, formerly known as juvenile diabetes, and Type 2 Diabetes 
Mellitus, formerly known as adult-onset diabetes.205 Type 1 diabetes is caused by the autoimmune 
destruction of pancreatic β-cells, the insulin producing cells of the body. Insulin is a vital hormone 
responsible for regulating carbohydrate and fatty acid metabolism in the human body, and without 
functioning β-cells type 1 diabetics are dependent on injections of synthetic insulin to survive.205 
Type 2 diabetes, on the other hand, is a state of dysfunctional blood glucose regulation as result of 
increased tolerance to insulin in the human body, called insulin resistance.200 Type 2 diabetes is 
highly associated with obesity and is treated foremost with diet and exercise, although drug therapies 
can also be used.205  
Despite different underlying pathologies, both Type 1 and Type 2 diabetes cause the same 
complications in patients as a result of prolonged periods of hyperglycemia.205 Diabetic 
hyperglycemia is defined by the American Diabetes Association as any blood glucose concentration 
higher than 11.1 millimolar (mM),205 which is twice the healthy upper limit of fasting blood glucose 
at 5.5 mM. However, pathological issues associated with diabetes and hyperglycemia are typically 
not observed until acute hyperglycemic concentrations exceed 20 mM.138,199,206–209 Diabetic 
complications are increasingly believed to be caused by the dysfunction of inflammatory processes 
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involving the macrophage,46,50 and include impaired wound healing,120,121 narrowing of arterial walls 
(atherosclerosis),47,122–125 kidney damage (diabetic nephropathy),126–130 and retinal damage (diabetic 
retinopathy).131–133 The lens can also be compromised by what is called diabetic cataract,134 the 
pathogenesis of which is not well understood but believed to be a result of metabolic and oxidative 
damage in a high glucose environment.134–136 Little work to date has examined the possible role of 
macrophages in diabetic complications of the lens. In the present study, we propose the use of a co-
culture model of macrophages and lens epithelial cells in hyperglycemic and isoglycemic conditions 
to further investigate the tissue environment of the lens in diabetes. 
3.1.1 Cell Culture 
The in vitro co-culture model developed in Chapter 2 was modified to isolate the effect of glucose 
concentration on the model. Changes to the macrophage, lens cell and co-culture protocols are 
detailed below. Unless otherwise noted, culture procedures were identical to those previously 
established in Section 2.2.1. 
3.1.1.1 Macrophage Culture 
THP-1 monocytes were maintained in suspension in RPMI 1640 media with 10% FBS and 
differentiated using PMA as described in Section 2.2.1.1. However, upon plating for differentiation 
THP-1 monocytes were incubated in a media mixture comprised of 67% v/v RPMI 1640 and 33% v/v 
DMEM. After 72 hours, media was replaced with a new mixture comprised of 33% v/v RPMI 1640 
and 67% v/v DMEM. After 48 hours, media was replaced with 100% DMEM for a final 48 hours 
until co-culture began. This process allowed THP-1 macrophages to be slowly transitioned from the 
higher glucose concentration found in RPMI 1640 (11 mM) to the lower glucose concentration of 
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DMEM (5.5 mM) through two intermediary concentrations of 9.185 mM (67% RPMI + 33% 
DMEM) and 7.315 mM (33% RPMI + 67% DMEM), as shown below in Table 3.1. 
Table 3.1: Cell-culture media combinations used to transition macrophages to low glucose 
Glucose Concentration Media Combination 
11 mM 100% RPMI + 0% DMEM 
9.185 mM 67% RPMI + 33% DMEM 
7.315 mM 33% RPMI + 67% DMEM 
5.5 mM 0% RPMI + 100% DMEM 
 
3.1.1.2 Lens Epithelial Cell Culture 
Prior to co-culture, HLE B-3 were cultured according to the protocol described in Section 2.2.1.2. To 
begin co-culture, 24-well polyethylene terephthalate 1-µm membrane hanging cell-culture inserts 
were inverted in a 6 well plate. To provide a more compliant surface for lens epithelial cell adhesion 
and therefore reduce background expression of intracellular stress fibres like αSMA210, inserts were 
coated with 0.05 mg/mL of collagen type I for 30 min at 37°C. After two washes with PBS, inserts 
were seeded with either 1 x 104, 2.5 x 104, 5 x 104 or 1 x 105 lens cells per insert, based on the 
intended length of co-culture: 6 and 12 hour co-cultures were seeded with 1 x 105 cells, 1 day co-
cultures were seeded with 5 x 104 cells, 2 day co-cultures with 2.5 x 104 cells and 6 day co-cultures 
with 1 x 104 cells. These seeding concentrations ensured a final cell density of approximately 1 x 105 
cells per insert while preventing overconfluence. Inserts were incubated overnight, and then returned 
to their normal orientation in serum-free media in a 24-well plate until the start of the co-culture. 
3.1.2 Co-culture 
To examine the effect of glucose concentration on the post-operative lens, HLE B-3 cells and THP-1 
macrophages were co-cultured or monocultured in DMEM with 10% FBS containing either 5.5 mM 
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D-glucose, representing non-diabetic physiologic blood glucose levels and referred to hereafter as 
“low glucose”, or 25 mM D-glucose, representing diabetic pathological blood glucose levels and 
referred to hereafter as “high glucose”. 1 x 105 disassociated mature THP-1 macrophages were added 
to two wells of a 24-well plate containing 1 mL of low glucose DMEM and two wells containing 1 
mL high glucose DMEM. Plates were incubated for 2 hours to allow for macrophage adherence. 
Hanging inserts with adherent HLE cells were then introduced to the co-culture plate. Two inserts 
were added to wells containing macrophages (one high glucose and one low glucose) and two inserts 
were introduced to blank wells with 1 mL of either high or low glucose DMEM. Co-culture plates 
were incubated for 6 hours, 12 hours, 1 day, 2 days or 6 days and then assayed for changes in cellular 
phenotype. Media was refreshed every 2 days. Upon the completion of co-culture, supernatant was 
collected and frozen at -20°C for assay at a later time. 
3.1.3 Immunolabelling and fluorescent reagents 
FITC conjugated mouse monoclonal antibody against CD36 (multi-ligand scavenger receptor), FITC 
conjugated mouse monoclonal antibody against CD11c (alpha chain subunit of complement receptor 
4), PE-Cy5 conjugated monoclonal antibody against CD45 (human leukocyte common antigen),  PE-
Cy5 conjugated monoclonal antibody against CD11b (alpha chain subunit of macrophage antigen-1 
or complement receptor 3), PE conjugated monoclonal antibody against CD54 (intercellular adhesion 
molecule 1 or ICAM1), PE conjugated mouse monoclonal antibody against CD14 (pattern 
recognition receptor), Alexa Fluor® 647 (AF647) conjugated mouse monoclonal antibody against E-
cadherin were purchased from Becton Dickinson Pharmingen (San Diego, CA, USA). PE conjugated 
monoclonal mouse antibody against vimentin, and FITC conjugated mouse monoclonal antibody 
against α-smooth muscle actin (α-SMA) were purchased from R&D Systems (Minneapolis, MN). As 
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a new α-SMA antibody was used, fluorescence values of α-SMA are not comparable to those 
presented in Chapter 2. All other chemicals were of analytical reagent grade. 
Both propidium iodide (PI) and a FLICA caspase kit were purchased from ImmunoChemistry 
Technologies (Bloomington, MN, USA). The FLICA kit uses the membrane-permeable, fluorescent –
pan caspase inhibitor FAM-VAD-FMK for caspase detection. 
3.1.4 Flow Cytometry 
Tissue digestion was performed as described in Section 2.2.5. Briefly, inserts containing adherent 
HLE cells were removed from the co-culture system, and wells containing macrophages were 
incubated at 37°C with TrypLE Express for 30 minutes. THP-1 cells were then centrifuged in media 
containing 10% FBS and re-suspended in 100 µL fresh media with serum. Aliquots of 50 µL were 
incubated in saturating concentrations of conjugated fluorescent monoclonal antibodies for 1 hour at 
room temperature in the dark. Leukocyte populations were identified by expression of CD45 or 
CD14. To assess macrophage behaviour, samples were split into two aliquots and incubated with one 
of two antibody combinations: FITC anti-CD36, PE anti-CD54 and PE-Cy5 CD45, or, FITC anti-
CD11c, PE anti-CD14 and PE-Cy5 anti-CD11b. After incubation, samples were diluted with HEPES-
Tyrode’s buﬀer and fixed with paraformaldehyde. Samples were read on a three-color FACSCalibur 
ﬂow cytometer. 
Inserts with adherent HLE cells were submerged in 0.25% Trypsin-EDTA and incubated at 
37°C for 2 hours on a shaker at 250 RPM. Once detached, cells were re-suspended in DMEM with 
10% FBS before centrifugation. Excess media was removed. Cells were re-suspended and then fixed 
in paraformaldehyde at a final concentration of 4% w/v for 15 minutes, at room temperature in the 
dark. Samples were washed, and cells were re-suspended and permeabalized with 0.5% Triton-X for 
5 minutes, at room temperature in the dark. Samples were then centrifuged and re-suspended in PBS 
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containing 1% w/v fatty-acid free BSA. Samples were separated into three aliquots and stained with 
antibodies against either α-SMA (FITC conjugated), E-cadherin (AF647 conjugated) or vimentin (PE 
conjugated) overnight, at 4°C in the dark. Samples were read the following morning on a three-color 
FACSCalibur ﬂow cytometer. 
3.1.4.1 Caspase Activity 
To assess the effect of different culture conditions on apoptosis and necrosis in macrophages and lens 
cells, caspase activity was measured by flow cytometry using the fluorogenic pan caspase inhibitor 
FAM-VAD-FMK, which fluoresces most intensely in cells with active caspases. Dead cells were 
identified by PI staining. As per the FLICA Kit instructions, cell suspensions were incubated with 
saturating concentrations of FAM-VAD-FMK for 60 minutes at 37°C. Samples were washed in 
caspase wash buffer three times before 0.5µL of PI was added. Caspase/PI samples were read 
immediately on a three-color FACSCalibur ﬂow cytometer.  
For each sample, cells were separated into four quadrants using post-acquisition gating on a 
plot of caspase fluorescence versus PI fluorescence. A typical plot of lens epithelial cells is shown 
below in Figure 3.1. Each quadrant delineates a subset of the population experiencing either 
apoptosis, cell death from apoptosis (secondary necrosis), necrosis, and live cells. Division into 
quadrants is performed by isolating the PI-positive and Caspase-positive population (cells 
experiencing secondary necrosis) into the upper-right Quadrant 2 (Q2). The same gating strategy was 
applied to all samples on the same cell-culture plate. The percentage of the total population within 
each quadrant was then analyzed for changes due to treatment or other factors. Additional examples 
of the gating strategy employed are included in Appendix A. 
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Figure 3.1: Representation of the gating strategy employed in live/dead analysis of lens 
epithelial cells and macrophages. Caspase fluorescence is plotted on the X-axis and PI 
fluorescence on the Y-axis. Shown here is a sample of lens epithelial cells that are mostly 
experiencing secondary necrosis. Quadrant 1 (Q1) depicts 3.03% of cells experiencing primary 
necrosis, Quadrant 2 (Q2) depicts 54.1% of cells experiencing secondary necrosis, Quadrant 3 
(Q3) depicts 15.0% of cells undergoing apoptosis and Quadrant 4 depicts 27.8% of cells as alive. 
3.1.5 Statistical Analysis 
Flow cytometry fluorescence values and percentage values are presented as the mean ± the standard 
error of the mean (SEM). Fluorescence and percentage values were subjected to a multivariate 
analysis of variance (ANOVA) using a general linear model, including terms for length of incubation, 
glucose concentration (high glucose vs. low glucose), and the culture condition (monoculture vs. co-
culture). Pairwise comparisons between glucose concentration, culture condition, incubation time, 
and glucose-culture-time combinations were performed using the Bonferoni comparison in Minitab 
16.2.3. A p value of less than 0.05 was required for significance. The number of experiments was 
always equal to or greater than three. 
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3.2 Results 
3.2.1 Culture with high glucose media down-regulates integrin expression 
The co-culture model was employed to determine the effect of glucose concentration on macrophage 
phenotype by examining cell-surface integrin expression. Overall, the co-culture model showed no 
difference on macrophage integrin expression when compared to a monoculture model. Integrin 
expression declined significantly over time (p < 0.05) for both high and low glucose culture media, 
with the decline occurring sooner (at 1 day of culture versus 6 days of culture) and more sharply with 
high glucose media. Glucose concentration in both models therefore had a prevailing, significant 
effect on all macrophage integrins beginning at 1 day of culture (p < 0.05). Significant differences 
between high and low glucose were observed at 2 days (p < 0.05) but not 6 days due to the decline in 
expression over time. 
 The intercellular adhesion molecule-1, otherwise known as CD54, was analyzed for changes 
in expression due to glucose concentration. As shown in Figure 3.2, macrophage monoculture and co-
culture in high glucose media significantly down-regulated CD54 expression at 1 day (monoculture: p 
= 0.0092, co-culture: p = 0.001) and 2 days (monoculture: p = 0.0025, co-culture: p = 0.0007) of 
incubation. In high glucose, CD54 expression peaked at 12 hours of incubation before decreasing 
very significantly by 1 day of incubation (monoculture: p = 0.0004, co-culture: p = 0.0001), where it 
remained nominally low through 2 and 6 days of incubation. In low glucose, CD54 expression peaked 
at 12 hours of incubation before decreasing significantly by 1 day of incubation (monoculture: p = 
0.0025), and decreasing yet again between 2 days and 6 days of incubation (monoculture: p = 0.0284, 
co-culture: p = 0.0025). 
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Figure 3.2: High glucose culture media down-regulates expression of CD54 in macrophages. 
Cells were cultured for 6 hours, 12 hours, 1 day, 2 days or 6 days in a monoculture (top) or in a 
lens co-culture system (bottom). CD54 expression was measured by flow cytometry and is 
reported as the mean ± the standard error of measurement (SE) of arbitrary fluorescence units 
(AFU). * indicates significant difference (p < 0.05); ** significant difference (p < 0.01), *** 
significant difference (p < 0.001), **** significant difference (p < 0.0001). n = 4 for all 
treatments and controls. 
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CD11c, an adhesion integrin, was also analyzed for changes in expression. As shown in 
Figure 3.3, macrophage monoculture and co-culture in high glucose media significantly down-
regulated CD11c expression at 1 day (monoculture: p = 0.0001, co-culture: p = 0.0001) and 2 days 
(monoculture: p = 0.0001, co-culture: p = 0.0001) of incubation. In high glucose, CD11c expression 
peaked at 12 hours of incubation before decreasing very significantly by 1 day of incubation 
(monoculture: p = 0.0003, co-culture: p = 0.0001), where it remained nominally low through 6 days. 
In low glucose, CD11c expression peaked at 12 hours of incubation but did not decline significantly 
until 6 days of culture (monoculture: p = 0.0001, co-culture: p = 0.0001). 
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Figure 3.3: High glucose culture media down-regulates expression of CD11c in macrophages. 
Cells were cultured for 6 hours, 12 hours, 1 day, 2 days or 6 days in a monoculture (top) or in a 
lens co-culture system (bottom). CD11c expression was measured by flow cytometry and is 
reported as the mean ± the standard error of measurement (SE) of arbitrary fluorescence units 
(AFU). * indicates significant difference (p < 0.05); ** significant difference (p < 0.01), *** 
significant difference (p < 0.001), **** significant difference (p < 0.0001). n = 4 for all 
treatments and controls. 
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The pattern recognition receptor CD14 exhibited similar patterns of expression to CD11c. As 
shown in Figure 3.4, macrophage monoculture and co-culture in high glucose media significantly 
down-regulated CD14 expression at 1 day (monoculture: p = 0.0007, co-culture: p = 0.0019) and 2 
days (monoculture: p = 0.0008, co-culture: p = 0.015) of incubation. In high glucose, CD14 
expression peaked at 12 hours of incubation before decreasing very significantly by 1 day of 
incubation (monoculture: p = 0.0029, co-culture: p = 0.0001), where it remained nominally low 
through 6 days. In low glucose, CD14 expression peaked at 12 hours of incubation but did not decline 
significantly until 6 days of culture (monoculture: p = 0.0242, co-culture: p = 0.0153). 
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Figure 3.4: High glucose culture media down-regulates expression of CD14 in macrophages. 
Cells were cultured for 6 hours, 12 hours, 1 day, 2 days or 6 days in a monoculture (top) or in a 
lens co-culture system (bottom). CD14 expression was measured by flow cytometry and is 
reported as the mean± the standard error of measurement (SE) of arbitrary fluorescence units 
(AFU). * indicates significant difference (p < 0.05); ** significant difference (p < 0.01), *** 
significant difference (p < 0.001), **** significant difference (p < 0.0001). n = 4 for all 
treatments and controls. 
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Unlike CD11c, the adhesion integrin CD11b exhibited no discernible peaks in expression and 
minimal time variance. As shown in Figure 3.5, high glucose media significantly down-regulated 
CD11b expression at 1 day (monoculture: p = 0.0001, co-culture: p = 0.0002) and 2 days 
(monoculture: p = 0.0001, co-culture: p = 0.0011) of incubation. In high glucose, CD11b expression 
declined significantly between 12 hours and 1 day of incubation (monoculture: p = 0.015, co-culture: 
p = 0.0006), where it remained through 6 days of incubation. In low glucose, CD11b expression 
declined significantly between 2 days and 6 days of incubation (monoculture: p = 0.0001, co-culture: 
p = 0.0001). 
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Figure 3.5: High glucose culture media down-regulates expression of CD11b in macrophages. 
Cells were cultured for 6 hours, 12 hours, 1 day, 2 days or 6 days in a monoculture (top) or in a 
lens co-culture system (bottom). CD11b expression was measured by flow cytometry and is 
reported as the mean ± the standard error of measurement (SE) of arbitrary fluorescence units 
(AFU). * indicates significant difference (p < 0.05); ** significant difference (p < 0.01), *** 
significant difference (p < 0.001), **** significant difference (p < 0.0001). n = 4 for all 
treatments and controls. 
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 Due to limited quantities of antibodies for the scavenger receptor CD36, changes in 
expression were measured only at 1 day, 2 days and 6 days of incubation. As shown in Figure 3.6, 
culture in high glucose media significantly down-regulated CD36 expression at 1 day (monoculture: p 
= 0.0001, co-culture: p = 0.0001) and 2 days (monoculture: p = 0.0001, co-culture: p = 0.0153) of 
incubation. In high glucose, CD36 expression levels remained consistently low over time. In low 
glucose, CD36 expression declined significantly between 1 day and 2 days of co-culture (co-culture: 
p = 0.0258) and between 2 days and 6 days of mono-culture (monoculture: p = 0.0001). 
The flow cytometry results of CD45 are included in Appendix B. 
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Figure 3.6: High glucose culture media down-regulates expression of CD36 in macrophages. 
Cells were cultured for 6 hours, 12 hours, 1 day, 2 days or 6 days in a monoculture (top) or in a 
lens co-culture system (bottom). CD36 expression was measured by flow cytometry and is 
reported as the mean ± the standard error of measurement (SE) of arbitrary fluorescence units 
(AFU). * indicates significant difference (p < 0.05); ** significant difference (p < 0.01), *** 
significant difference (p < 0.001), **** significant difference (p < 0.0001). n = 4 for all 
treatments and controls. 
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3.2.2 High glucose media delays macrophage apoptosis and decreases necrosis 
A FLICA kit from ImmunoChemistry Technologies was used to examine the possible effect of 
elevated glucose concentration on macrophage apoptosis. As shown in Figure 3.7, the number of 
apoptotic macrophages in both monoculture and co-culture increased significantly over time to a 
maximum of 69% of cells undergoing apoptosis. In high glucose, the proportion of apoptotic cells 
remained low between 6 hours and 1 day of incubation (around 35% of all cells) before significantly 
increasing to 69% at 2 days of culture (monoculture: p = 0.0072, co-culture: p = 0.0028). In low 
glucose, a significant increase in the proportion of apoptotic cells was observed earlier, at 1 day of 
culture (monoculture: p = 0.0297, co-culture: p = 0.0083). No significant difference in the proportion 
of apoptotic cells was observed between high and low glucose media. 
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Figure 3.7: High glucose culture media delays macrophage apoptosis. Cells were cultured for 6 
hours, 12 hours, 1 day, 2 days or 6 days in a monoculture (top) or in a lens co-culture system 
(bottom). Caspase activity was measured by flow cytometry and is reported as the percentage of 
cells staining positively for caspase and negatively for PI ± the standard error of measurement 
(SE). * indicates a significant difference (p < 0.05), ** indicates (p < 0.01). n = 4 for all 
treatments and controls. 
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Likewise, the nucleic stain PI was used to examine the effect of elevated glucose 
concentration on macrophage necrosis. As shown in Figure 3.8, monoculture with high glucose media 
significantly reduced the proportion of necrotic cells at 1 day of monoculture (p = 0.0424) compared 
to monoculture in low glucose media. In high glucose media, the proportion of necrotic cells peaked 
at 12% of cells at 12 hours of monoculture before significantly decreasing to 5% by 1 day of 
monoculture (p = 0.0162), compared to around 10% of cells in low glucose at 1 day. These trends 
were not observed in the co-culture model, though no significant difference was observed between the 
monoculture and co-culture models. 
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Figure 3.8: High glucose culture media decreases macrophage necrosis. Cells were cultured for 
6 hours, 12 hours, 1 day, 2 days or 6 days in a monoculture (top) or in a lens co-culture system 
(bottom). PI staining was measured by flow cytometry and is reported as the proportion of 
macrophages staining positively for PI ± the standard error of measurement (SE). * indicates a 
significant difference (p < 0.05). n = 4 for all treatments and controls. 
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3.2.3 Lens epithelial cell phenotype is unaffected by high glucose media 
The co-culture model was also employed to determine the effect of glucose concentration on lens 
epithelial cell phenotype by examining expression of the cytoskeletal proteins α-SMA and vimentin, 
and the transmembrane protein E-cadherin. No differences in α-SMA, vimentin or E-cadherin 
expression were observed between high and low glucose media at any time point (p > 0.05), as shown 
in Table 3.2. Similar to the examination of macrophage integrin expression, no differences in E-
cadherin and vimentin expression were observed between the co-culture model and the monoculture 
model. However, the presence of macrophages induced a small increase in α-SMA expression at 6 
days of culture: a similar finding to that of Chapter 2. Expression of all three proteins remained 
constant over time, except for α-SMA. Please note that a new α-SMA antibody was used in this 
investigation, and values are therefore not comparable to those presented previously. 
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Table 3.2: α-SMA, vimentin and E-cadherin expression on lens epithelial cells cultured for 6 
hours, 12 hours, 1 day, 2 days or 6 days in media containing high or low glucose concentrations. 
Protein expression was measured by flow cytometry and is reported as the mean of arbitrary 
fluorescence units (AFU) ± the standard error of measurement (SE). 
Culture Model Incubation time Glucose Level α-SMA Vimentin E-cadherin 
Monoculture 
6 hours 
High 4 ± 0.4 38.0 ± 8 13 ± 0.5 
Low 5 ± 0.4 43.7 ± 1 14 ± 1 
12 hours 
High 6 ± 2 72 ± 6 18 ± 2 
Low 6 ± 2 84 ± 12 18 ± 2 
1 day 
High 4 ± 0.7 61 ± 9 12 ± 0.7 
Low 6 ± 2 54 ± 8 14 ± 0.4 
2 days 
High 10 ± 2 79 ± 11 14 ± 0.9 
Low 10 ± 2 64 ± 10 14 ± 2 
6 days 
High 5 ± 1 61 ± 10 16 ± 0.8 
Low 10 ± 2 81 ± 17 14 ± 0.8 
Co-culture 
6 hours 
High 5 ± 0.4 41 ± 14 13 ± 3 
Low 4 ± 0.8 46 ± 17 13 ± 3 
12 hours 
High 4 ± 2 45 ± 2 13 ± 0.6 
Low 4 ± 1 50 ± 10 12 ± 0.8 
1 day 
High 5 ± 1 75 ± 15 12 ± 1 
Low 9 ± 1 54 ± 7 13 ± 0.5 
2 days 
High 9 ± 2 78 ± 18 15 ± 2 
Low 9 ± 1 74 ± 15 13 ± 3 
6 days 
High 6 ± 2 58 ± 7 16 ± 1 
Low 11 ± 1 77 ± 11 15 ± 1 
 
3.2.4 High glucose media delays lens epithelial cell necrosis but not apoptosis 
The effect of high and low glucose media on lens epithelial cell apoptosis was evaluated using a 
FLICA kit. No difference in the proportion of apoptotic cells was observed between the co-culture 
model and monoculture model, shown below in Figure 3.9. Similarly, no significant difference in the 
proportion of apoptotic cells was observed between culture with high glucose media and culture with 
low glucose media. As well, no significant changes in the proportion of apoptotic cells was observed 
over time. 
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Figure 3.9: The proportion of lens epithelial cells undergoing apoptosis over time is not affected 
by glucose concentration. Cells were cultured for 6 hours, 12 hours, 1 day, 2 days or 6 days in a 
monoculture (top) or in a macrophage co-culture system (bottom). Caspase activity was 
measured by flow cytometry and is reported as the percentage of cells staining positively for 
caspase and negatively for PI. n = 4 for all treatments and controls. 
Monoculture
6 hours 12 hours 1 day 2 days 6 days
0
20
40
60
80
Low Glucose
High Glucose
Incubation Time
P
e
rc
e
n
t 
o
f 
C
e
lls
 i
n
 A
p
o
p
to
s
is
Co-culture
6 hours 12 hours 1 day 2 days 6 days
0
20
40
60
80
Low Glucose
High Glucose
Incubation Time
P
e
rc
e
n
t 
o
f 
C
e
lls
 i
n
 A
p
o
p
to
s
is
  71 
 
The effect of high and low glucose media on lens epithelial cell death was evaluated using PI. 
No significant difference was observed in the proportion of necrotic cells between the co-culture 
model and monoculture model, shown below in Figure 3.10. Further, no significant difference in the 
proportion of necrotic cells was observed between culture with high glucose media and low glucose 
media. However, in low glucose media, the proportion of necrotic cells increased significantly 
between 6 hours and 1 day of monoculture, from 20% to 55% of cells (p = 0.005). In high glucose 
media, the proportion of necrotic cells remained low between 6 and 12 hours of monoculture (around 
23%) before increasing significantly at 1 day of monoculture to 65% (p = 0.0007).  
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Figure 3.10: High glucose culture media delays necrosis of lens epithelial cells. Cells were 
cultured for 6 hours, 12 hours, 1 day, 2 days or 6 days in a monoculture (top) or in a 
macrophage co-culture system (bottom). PI staining was measured by flow cytometry and is 
reported as the proportion of lens epithelial cells staining positively for PI. ** indicates a 
significant difference (p < 0.01), *** indicates (p < 0.001). n = 4 for all treatments and controls. 
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3.3 Discussion 
The novel co-culture model developed in Chapter 2 to examine the relationship between macrophages 
and lens epithelial cells in the post-operative lens was used to explore interactions in conditions that 
would mimic the environment of a lens during diabetes. To isolate the effect of elevated glucose 
levels, co-culture and monoculture of both cell types was performed using the same media 
formulation in either a high (25 mM) or low (5.5 mM) glucose concentration variant. DMEM was 
selected due to its extended history of use with both HLE B-3 cells,211–214 and macrophages,215,216 a 
history not shared with RPMI. Further, since RPMI has a base glucose concentration of 11 mM, it 
falls within the American Diabetes Association’s definition of hyperglycemia,205 and is therefore 
inappropriate for use in this study. The DMEM media formulation is loosely based on physiological 
blood concentrations. Although the concentration of glucose in the aqueous humor of a non-diabetic 
is as much as 50% lower than that of blood,14 the relative increase in aqueous humor glucose 
concentration observed during diabetes is consistent to that seen in blood. 
Our objective was to examine the cellular response of THP-1 macrophages to high glucose 
culture media, and the effect of this response on HLE B-3 lens epithelial cell phenotype. 
Glycoproteins and integrins that enable macrophage adhesion to and infiltration of the endothelium, 
like CD54 and CD11b, have been thoroughly examined in vivo for their contributions to diabetic 
complications. Although a role for CD11c in diabetic complications and in relation to sugar level has 
not been reported, its regulation by many of the same pathways as CD11b is well understood.217,218 
Increased CD54 expression has been observed on endothelial cells during hyperglycemia, enabling 
recruitment of leukocytes out of the circulatory system.124,125,127,129–131,133,219–221 However, studies 
examining CD54 and CD11b expression on the membrane of inflammatory cells during 
hyperglycemia have shown mixed results. Sampson et al. reported increases in CD11b, CD54 and 
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CD11a expression on monocytes as a result of acute hyperglycemia in diabetics and nondiabetics.208 
Cifarelli ei al. reported increased CD11b expression but decreased CD54 expression on monocytes 
obtained from Type-1 diabetic children within one week of their diagnosis compared to 2 months 
after diagnosis, attributing the difference to better blood-glucose management.44 Torrecilla et al. 
demonstrated up-regulation of CD54 and CD11a and no change in CD11b expression after induction 
of hyperglycemia.222 Although these studies examined monocytes prior to their terminal 
differentiation into macrophages, and therefore cannot be extrapolated to macrophage response, they 
illustrate the lack of consensus regarding the regulation of leukocyte adhesion protein expression 
during hyperglycemia.  
In the present study, all three adhesion molecules – CD54, CD11b and CD11c – exhibited a 
peak in expression at 12 hours of incubation followed by a subsequent significant decline by one day. 
However, we observed a significant down-regulation of all adhesion integrins at one and two days of 
incubation in high glucose culture media compared to low glucose culture media. Similar 
observations were made by Sun et al., who demonstrated that macrophages isolated from long-term 
diabetic mice displayed significantly down-regulated CD54 expression and secretion of TNF-α and 
IL-6 but significantly increased NO secretion when stimulated with LPS and IFN-γ compared to 
control mice.138 Takahashi et al. demonstrated that monocyte-derived dendritic cells in pre-diabetic 
adult patients showed impaired yield and integrin expression compared to healthy patients.223 Štulc et 
al. observed a significant increase in expression of CD54, CD11a, CD18 and CD14 on monocytes 
extracted from patients with diabetes compared to without, but highlighted the absence of a 
correlation between leukocyte integrin expression and serum glucose concentration.224 The results 
presented in the current study may suggest that another factor of the diabetic disease state, and not 
hyperglycemia, may be responsible for the reported increases in leukocyte integrin expression.  
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The bacterial pattern recognition receptor CD14 was examined as a measure of non-specific 
immunological activity.225 As was the case with macrophage adhesion proteins, previous work 
examining the expression of CD14 during hyperglycemia and diabetes has returned conflicting 
results. Patiño et al. observed upregulated CD14 expression on circulating monocytes taken from 
Type-2 diabetics versus healthy subjects.226 Fogelstrand et al. reported higher CD14 expression on 
monocytes extracted from Type-2 diabetics compared to healthy subjects, with pre-diabetic subjects 
displaying intermediary CD14 expression.227 Interestingly, Fogelstrand et al. noted stronger 
correlations between CD14 expression and subject Body Mass Index (BMI) and plasma insulin 
concentration, and a weak correlation to blood glucose levels.227 Previously mentioned work by Štulc 
et al. reported upregulation of monocyte CD14 expression in diabetics with a weak correlation to 
blood glucose concentration.224 In contrast, Nareika et al. reported no difference between U937 
mononuclear cells cultured in high glucose for two weeks compared to those cultured in low glucose 
for two weeks.228 In the present study, we observed a significant down-regulation of CD14 expression 
on macrophages cultured in high glucose for one and two days compared to those cultured in low 
glucose. As the in vivo work reporting CD14 upregulation with diabetics noted weak correlations to 
blood glucose, and the work of Nareika et. al directly examining the effect of high glucose levels on 
macrophage reported no such effect, it seems plausible that aspects of diabetes mellitus other than 
hyperglycemia are responsible for the observed increases in CD14 expression. 
The effects of hyperglycemia on the scavenger receptor CD36 are well established. Early 
work by Griffin et al. demonstrated an upregulation of CD36 expression on macrophages ex vivo after 
5 days of hyperglycemic culture.204 However, Sampson et al. reported higher CD36 expression on 
monocytes isolated from Type-2 diabetic patients compared to healthy subjects with no resulting 
effect of induced hyperglycemia.229 It was Liang et al. who proposed that the increase in CD36 
expression on macrophages observed during diabetes might be a result of defective insulin signalling, 
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or insulinopenia.158 This hypothesis was corroborated by Yechoor et al. using insulin-deficient 
knockout mice.230  Chen et al. showed that both insulin treatment and treatment with the drug 
vanadate, which reduces blood glucose by other means than insulin receptor action, reduced 
expression of CD36 in the small intestine mucosa of rats to baseline levels.231 In the present study, we 
observed a significant down-regulation of CD36 expression on macrophages cultured in 
hyperglycemic conditions. Additionally, we observed a decline in CD36 expression over time on 
macrophages cultured in isoglycemic conditions. Interestingly, a similar reduction in CD36 
expression has been demonstrated as a result of hypertension and insulin resistance.232,233 It may be 
that prolonged culture with THP-1 macrophages in high glucose media results in defective insulin 
signalling, causing down-regulated expression of CD36. Unfortunately, no further explanation of the 
results reported herein can be offered. 
The strong decline in integrin expression observed in the present study could be explained by 
an increase in macrophage apoptosis, during which translation of live cell functional proteins like 
integrins is silenced. Intermediate products of the glycation process were reported by Okado et al. to 
induce apoptosis in the U937 macrophages at hyperglycemic concentrations via increases in oxidative 
stress.234 However, Turina et al. reported that neither hyperglycemia nor hypoglycemia induced 
significant apoptotic turnover of neutrophils.235 In the present study, nearly 70% of macrophages 
displayed a high degree of caspase activity, which is taken to mean they are undergoing apoptosis. 
However, THP-1 cells have been shown to constitutively express caspase-1 and caspase-3 for use as 
regulators of cytokine production.236 Further, in macrophages caspase-1 has been demonstrated to 
regulate the secretion of important signalling proteins in inflammation, cytoprotection and tissue 
repair.237 Therefore, the high caspase activity observed in the present study may partly be explained 
by processes other than apoptosis. While any increase in caspase activity over time is likely the result 
of increasing apoptosis, the high baseline value may be the result of caspase activity in other 
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intracellular processes. Further, the high baseline could be explained by an overly-conservative gating 
strategy that selects more cells as apoptotic than is the case. Looking at the percentage of secondary 
necrotic cells indicates that only as many as 5% of cells at 6 days of culture died as a result of 
apoptosis – far, far fewer than should be with nearly 70% of cells undergoing apoptosis at 2 days of 
culture. Additional control experiments will be required to determine if the flow cytometry settings 
can be improved, or if caspase activity is inherently present in differentiated THP-1 macrophages. 
In the present study, there was a significant trend of increasing macrophage apoptosis over 
time in both high and low glucose media. However, the increase in apoptosis was more gradual and 
occurred at a later time point in high glucose media than in low glucose media. This difference was 
non-existent by two days of cell culture, due to an eventual increase in apoptosis in high glucose 
media. Compared to low glucose media, culture in high glucose media caused a significant decrease 
in the number of necrotic macrophages at one day of culture, where it remained lower through to 6 
days of culture. The combination of delayed caspase activity and reduced necrosis over time in high 
glucose culture media implies that hyperglycemia may delay macrophage cell death. A reduction in 
the rate of cells beginning apoptosis would explain a reduction in the number of dead cells over time. 
In the body, it may be that an adverse delay in macrophage cell death enables the pathological 
inflammatory issues observed during diabetic complications by prolonging the wound-healing 
response. 
No difference was observed in monocultured lens epithelial cell expression of α-SMA, 
vimentin or E-cadherin were encountered. These results reinforce the current understanding that 
diabetic cataracts are a result of accumulated oxidative damage due to the osmotic stress of a 
hyperglycemic aqueous humor,135,136,202,238 and not the result of phenotypic changes in lens epithelial 
cells as seen during PCO.134,239,240 Further, the presence of macrophages had no effect on lens 
epithelial cell phenotype except for causing an increase in α-SMA expression in both media 
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conditions. This result confirms the findings of Chapter 2, which utilized low glucose media and 
determined that the presence of resting macrophages was sufficient for an increase in α-SMA 
expression. Since macrophages in the present study were observed as undergoing a significant 
phenotypic shift in hyperglycemic conditions, the lack of observable difference between 
monocultured and co-cultured lens epithelial cells in high glucose media indicates that the 
hyperglycemic changes to macrophage phenotype reported here have no effect on lens epithelial cell 
phenotype. Drawing on the conclusions of Chapter 2, the perceived lack of effect may be the result of 
either a low level of macrophage activation, or too low a ratio of macrophages to lens epithelial cells 
in the co-culture system.  
The concentration of glucose in culture media had no discernible effect on the rate of lens 
epithelial cell apoptosis, which increased slightly over time from 40% of cells at 1 day to 50% of cells 
at 6 days. However, culture with high glucose media did induce a significant increase in lens 
epithelial cell necrosis at 1 day of culture compared to 12 hours, reaching nearly 65% of cells. Cells 
cultured in low glucose media displayed a steady increase in necrosis up to 1 day of culture where it 
remained high. Cells cultured in high glucose, however, showed very little necrosis (less than 20% of 
cells) until the sharp increase at 1 day. The increase in necrosis without an accompanying increase in 
apoptosis may imply the effect of a cell death mechanism other than caspase-dependent apoptosis.241  
The presence of oxidative metabolic by-products of glucose in culture media have been 
demonstrated to induce lens epithelial cell necrosis both without apoptosis,242 and with apoptosis.243 
Lens epithelial cells have also been shown to undergo apoptosis in the presence of by-products of 
lipid metabolism.244 Since the physiologic glucose concentration of the aqueous humor is 
approximately half the concentration of the blood and our low glucose media formulation, it may be 
that HLE B-3 cells cultured in low glucose DMEM are experiencing hyperglycemia, and therefore, 
elevated apoptosis. As the role of glucose metabolism in lens epithelial cell apoptosis is well 
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understood, the results of the present study may further support our current understanding of diabetic 
cataracts as the result of oxidative stress in the lens. Further, Shui et. al observed lens epithelial cell 
phagocytosis, and digestion, of neighbouring necrotic and apoptotic cells,245 which may explain the 
high baseline caspase activity herein. However, it seems likely that the gating strategy – which was 
designed to accurately capture secondary-necrotic cell populations – is overestimating the amount of 
caspase activity in non-necrotic cells. 
3.4 Conclusion 
The novel in vitro co-culture model designed for biocompatibility testing of intraocular materials was 
applied to another possible pathological interaction between lens epithelial cells and macrophages: 
the development of diabetic cataract. Although macrophage phenotype appears heavily affected by 
hyperglycemic conditions, lens epithelial cells appeared phenotypically stable under monoculture in 
hyperglycemic conditions, and under macrophage co-culture in hyperglycemic conditions. 
Macrophage apoptosis appeared delayed under hyperglycemic conditions, consequentially reducing 
the rate of necrosis and highlighting a possible mechanism for adverse macrophage behaviour in 
diabetic complications. Lens epithelial cell apoptosis remained unaffected by glucose concentration, 
although necrosis was increased in hyperglycemic conditions. These findings further the current 
understanding that diabetic cataracts are not an inflammatory complication of diabetes, but rather a 
result of the inability of lens epithelial cells to accommodate hyperosmolar conditions in the aqueous 
humor. Additional work should explore the oxidative stress in THP-1 derived macrophages during 
hyperglycemic culture and the possible changes in secretory products that may result. 
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Chapter 4: Conclusions and Recommendations 
The role and behaviour of macrophages in the immune privileged environment of the eye, specifically 
with regard to disease, are not well understood. Evidence for macrophage participation in the 
development of secondary cataracts provided the motivation for this investigation. The crucial role of 
macrophage dysfunction during diabetic complications further motivated the exploration of 
macrophage interaction with cells of the inner eye. A novel in vitro model of macrophages and lens 
epithelial cells in co-culture was developed and used to examine the role of macrophages in two 
afflictions of the lens epithelium: posterior capsule opacification, and diabetic cataract.  
In the present study, macrophage biocompatibility with materials commonly used in cataract 
surgery influenced lens epithelial cells toward dysfunctional behaviour. Specifically, hydrophilic 
surfaces activated macrophages and prevented adhesion more than hydrophobic ones. However, 
macrophage interaction with both materials induced the same degree of inflammatory phenotype 
disruption in lens epithelial cells. We conclude that macrophage adhesion and activation are inversely 
related, in agreement with countless studies of macrophage biocompatibility elsewhere in the body. 
We also conclude that the net inflammatory effect of macrophage interaction is a function of the 
degree of macrophage activation and number of activated macrophages. 
 In this thesis, we hypothesized that changes in glucose concentration and the introduction of a 
secondary cell population would induce changes in primary cell behaviour. The effects of glucose 
concentration and co-culture on the expression of leukocyte receptors involved in adhesion and 
activation, as well as cytoskeletal proteins of the lens epithelium, are summarized in Table 4.1. 
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Table 4.1: Summary table of time trends and co-culture effects on macrophage and lens 
epithelial cell protein expression in all three media formulations. Data gathered from Chapter 2 
and Chapter 3. ↑ indicates increased expression, ↓ indicates decreased expression, = indicates no 
effect. Proteins not measured with a certain media formulation are left blank. (5.5 mM) refers 
to a glucose concentration of 5.5 mM. 
  Trend over time Effect of co-culture 
Marker 
 DMEM  
(5.5 mM) 
RPMI 
(11 mM) 
DMEM 
(25 mM) 
DMEM  
(5.5 mM) 
RPMI 
(11 mM) 
DMEM 
(25 mM) 
CD54  ↓ ↓ ↓ = = = 
CD45  ↓ ↓ ↓ = = = 
CD36  ↓ ↓ ↓ = = = 
CD14  ↓ ↑ ↓ = = = 
CD11b  ↓  ↓ = = = 
CD11c  ↓  ↓ = = = 
α-SMA  ↑ ↑ ↑ ↑ ↑ ↑ 
Fibronectin   ↓   =  
Vimentin  ↑  ↑ =  = 
E-cadherin  = = = = = = 
 
A significant disruption of macrophage phenotype and behaviour was observed during 
hyperglycemic conditions. Specifically, a stark decrease in the expression of macrophage cell-surface 
proteins during hyperglycemia was observed, the effect of which is currently not well understood. In 
contrast, there was no change in protein expression in lens epithelial cells during hyperglycemia, 
providing additional evidence to support the hypothesis that diabetic cataract is not a result of 
phenotypic changes. Additionally, a delay in macrophage apoptosis during hyperglycemia was 
observed and appears to correspond to reduced rates of macrophage death which may explain the 
adverse inflammatory reaction observed in diabetes. Results from our in vitro model also suggest that 
lens epithelial cell death as a result of hyperglycemia occurs through a mechanism other than 
apoptosis, in agreement with previous in vitro work from other research groups. We therefore provide 
  82 
additional evidence to the hypothesis that diabetic cataracts are a product of accumulated oxidative 
stress during hyperglycemia. 
Our model enables a new method of inquiry into macrophage biocompatibility testing with 
intraocular materials. Specifically, cell-surface proteins involved in leukocyte activation have been 
quantified for the first time with regards to intraocular materials, providing additional evidence for the 
influence of macrophages in the development of posterior capsule opacification. Further, the absence 
of interaction between macrophages and lens epithelial cells during hyperglycemia, and observed 
direct effect of hyperglycemia on lens epithelial cells, provides additional evidence to the hypothesis 
that diabetic cataracts are an oxidative complication unlike diabetic retinopathy. The findings 
presented herein, although far from conclusive, begin to answer the question of what role the 
macrophage might play in the immune privileged environment of the inner eye. 
Future work should focus on the iterative refinement of the in vitro model. The movement to 
more compliant and biocompatible cell-culture substrates should yield improvements in background 
levels of macrophage activation and lens epithelial cell inflammation. Further, the use of primary 
(non-immortalized) cell lines or ex vivo tissue samples should improve the representation of the in 
vivo environment. To that end, the development of an artificial aqueous humor and its use with the 
co-culture model would greatly improve the investigation of macrophage and lens epithelial cell 
interaction in the immune privileged intraocular environment. Given the strong effect of 
hyperglycemia on macrophage phenotype, future experiments should examine uveal biocompatibility 
under high glucose conditions. As well, the change in glucose concentration over the time of culture 
should be elucidated and correlated with macrophage phenotype. Lastly, whether elevated glucose 
concentration resulted in excessive lactate buildup in the culture media was not examined and may 
provide a future avenue of investigation.   
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Appendix A 
Supplementary Figures for Chapter 2 
The differentiation protocol employed in this thesis was evaluated to determine the optimal length of 
differentiation to produce large but viable macrophages. As shown in Table A.1, by Day 8 of 
differentiation the THP-1 macrophages are 2.2x the volume of their monocyte precursor while still 
nearly 82% viable. An additional day of differentiation, however, results in a viability drop to 78% 
intact cells and a small decrease in volume despite a higher mean diameter. On this basis, it was 
decided to end differentiation on Day 8 instead of Day 9 as carried out in work by Daigneault et al. 
 Cell morphology was analyzed using a Moxi Z automated cell counter (Orflo Technologies, 
Ketchum, Idaho), which measures cell diameter and volume using the Coulter Principle. The Moxi Z 
also provides a crude live/dead analysis of each sample by comparing the proportion of counted 
objects in the approximate diameter range of human cells to the proportion of particles below the 
expected size of human cells. Data for monocytes prior to differentiation, macrophages at 8 days of 
differentiation and macrophages at 9 days of differentiation are included below. 
Table 4.2: Summary of morphological characteristics of THP-1 cells through the differentiation 
process into macrophages. * indicates a significant difference (p < 0.0001) and + indicates a 
significant difference (p < 0.001). 
Number of Days into 
Differentiation 
Cell Type 
Mean Diameter 
(µm) 
Mean 
Volume (pL) 
Ratio of Cells 
to Debris 
Day 0 Monocyte 13.7401 1.3594 0.914 
Day 8 Macrophage 18.2977* 3.2167* 0.8167+ 
Day 9 Macrophage 19.1673* 3.1717* 0.7767+ 
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Included below are representations of the gating strategy employed in the live/dead analysis 
of macrophages at each time point in the culture process. Note that each figure is a single sample and 
may not depict the mean value of all samples for that time point. 
 
Figure 4.1: Gating strategy for live/dead analysis of macrophages at 6 hours of monoculture. 
Left: high glucose. Right: low glucose. 
  85 
 
Figure 4.2: Gating strategy for live/dead analysis of macrophages at 12 hours of monoculture. 
Left: high glucose. Right: low glucose. 
 
Figure 4.3: Gating strategy for live/dead analysis of macrophages at 1 day of monoculture. Left: 
high glucose. Right: low glucose. 
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Figure 4.4: Gating strategy for live/dead analysis of macrophages at 2 days of monoculture. 
Left: high glucose. Right: low glucose. 
 
 
Figure 4.5: Gating strategy for live/dead analysis of macrophages at 6 days of monoculture. 
Left: high glucose. Right: low glucose. 
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Appendix B 
Supplementary Figures for Chapter 3 
 
 
Figure 4.6: High glucose culture media down-regulates expression of CD45 in macrophages. 
Cells were cultured for 6 hours, 12 hours, 1 day, 2 days or 6 days in a monoculture (top) or in a 
lens co-culture system (bottom). CD45 expression was measured by flow cytometry and is 
reported as the mean of arbitrary fluorescence units (AFU). * indicates significant difference (p 
< 0.05); ** significant difference (p < 0.01), *** significant difference (p < 0.001), **** 
significant difference (p < 0.0001). n = 4 for all treatments and controls. 
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As shown in Table 4.1, macrophage culture in high glucose media caused a significant down-
regulation of the leukocyte common antigen CD45 at 1 day of incubation (monoculture: p = 0.0019, 
co-culture: p = 0.0001) and 2 days (monoculture: p = 0.0096). In low glucose, CD45 expression 
peaked at 1 day of co-culture with a significant decline by 6 days of co-culture (p = 0.0001) while 
monoculture produced no discernible time variation. In high glucose, CD45 expression peaked at 12 
hours of co-culture with a significant decline by 6 days of co-culture (p = 0.0155), while monoculture 
resulted in a steady but insignificant decline. 
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Glossary of Terms 
Adaptive immune system: the subsystem of the immune system with memory for specific antigens. 
Adsorption: the adhesion of a protein or molecule to a surface. 
Antibody: small proteins of the adaptive immune system used to identify and attack antigens. 
Antigens: any substance that induces an immune response. 
Apoptosis: programmed cell death. 
AFU: arbitrary fluorescence units. 
BAB: blood aqueous barrier. 
CD: cluster of differentiation. A naming convention used for various cell-surface proteins in humans. 
Cytokine: small secreted proteins that mediate a number of biological processes. 
DCF: formally, the fluorescent molecule 2',7'-dichlorofluorescein. Informally, the DCFH2 probe. 
ELISA: enzyme-linked immunosorbent assay. 
FBGC: foreign body giant cell. 
Haptic: the plastic side pieces of an intraocular lens (IOL). 
Hydrophilic: water-attracting. 
Hydrophobic: water-repelling. 
Innate immune system: the non-specific subsystem of the immune system. 
Integrin: transmembrane receptor proteins involved in intercellular & extracellular matrix adhesion. 
IOL: intraocular lens. 
IL: Interleukin. Family of cytokines. 
Leukocyte: white blood cells. The cells of the immune system. 
Macrophage: the phagocytising cell of the innate immune system. Mediates wound-healing. 
Microparticle: small membrane-bound compartments released by activated and dying cells. 
Monocyte: precursor cells of the macrophage. Circulate in the blood. 
Pathogen: invasive organisms that produce disease. Bacteria, viruses, parasites and fungi. 
Pattern recognition receptor: cell-surface proteins that recognise common molecules of pathogens. 
PCO: posterior capsule opacification. The re-emergence of cataract following phacoemulsification. 
Phacoemulsification: modern cataract extraction surgery. 
pHEMA: poly(2-hydroxyethyl methacrylate). A polymer used to produce hydrophilic materials. 
PMMA: poly(methyl methacrylate). A polymer used to produce hydrophobic materials. 
ROS/RNS: reactive oxygen species, or, reactive nitrogen species. 
TCPS: Tissue culture polystyrene. Common basement material used in cell-culture. 
TGF-β: Transforming growth factor beta. Cytokine that controls tissue-remodelling and proliferation. 
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